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Adipose tissue is a dynamic endocrine organ that contains both the problem and the 
solution to discovering new therapies for individuals with obesity. Excessive adipose 
tissue disrupts energy balance and causes a host of comorbidities like insulin resistance 
and hypertension. On the other hand, adipose tissue is essential for life. During periods 
of energy demand, sympathetic nerve activity in brown and white adipose tissue 
stimulates thermogenesis and lipolysis; both of which decrease body weight and 
improve metabolic health. Therefore, comprehensive insight into the organization of 
sympathetic innervation and how it communicates with adipocytes is critical in order to 
utilize its capacity to reduce body weight and improve metabolic health. Recent 
literature enhances the confusion about the neuronal origin of postganglionic 
sympathetic innervation, and little is known about preganglionic inputs. Here we inject a 
retrograde transsynaptic tracer, pseudorabies virus (PRV), into the right interscapular 
brown adipose tissue (iBAT) pad and the inguinal WAT (iWAT) pad of mice to label pre- 
and postganglionic neurons that innervate iBAT and iWAT, respectively. To ensure a 
thorough investigation into the sympathetic structures, we established a whole-body 
tissue clearance method combined with a double immunohistological detection to 
identify sympathetic nerves and adipose tissue-related sympathetic circuits. Three-
dimensional images generated with light sheet microscopy allowed for an 
unprecedented view of abdominal sympathetic structures. iBAT postganglionic 
innervation was found to be restricted to sympathetic chain ganglia (SChG) from the 
stellate ganglion (SG) to thoracic ganglion 5 (T5), while preganglionic innervation was 
found from T1-T5. iWAT postganglionic innervation was found at T12 to lumbar 
 viii 
ganglion 1 (L1), while preganglionic innervation was found from T7-T10. Importantly, 
PRV labeling was not identified in the prevertebral celiac ganglia. These novel 
observations demonstrate that the population of pre- and postganglionic neurons 
innervating iBAT and iWAT are distinct from one another.  
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Chapter 1. Introduction 
1.1. Characterization of adipose tissue 
1.1.1. Evolution of adipose tissue 
The field of adipose tissue research has seen tremendous advancements within the last 
50 years, likely due in large part to the increased prevalence of obesity and metabolic 
syndrome in humans. As the community at-large struggles to identify an efficacious 
treatment for obesity, it has become clear that adipose tissue is much more intricate 
than once hypothesized1-8. In fact, forms of adipose tissue can be observed across the 
taxonomic ranks. For this reason, researchers study the phylogenetics of adipose tissue 
with the idea that the evolution of adipose tissue can help answer questions that prevail 
in the field today.   
Indeed, studies have provided intriguing findings about the similarities in whole-
body metabolic regulation between invertebrates and vertebrates. Numerous species of 
invertebrates possess specialized tissues that regulate metabolism, the most thoroughly 
investigated being the “fat body.” Reminiscent of vertebrate adipocyte function, the 
insect fat body stores lipids as triacylglycerol (TAG), and releases their breakdown 
products when demand is signaled from other tissues9,10. Similar to adipose tissue, the 
fat body has a role in a variety of biological functions that include nutrition, reproduction, 
longevity, and production of antimicrobial peptides10. Additionally, two significant 
signaling molecules in metabolism, Neuropeptide Y and insulin, have also been 
identified in invertebrates11-13. Interestingly, the invertebrate sea squirt, Ciona, has most 
of the signals and receptors implicated in appetite and energy storage in mammals14,15. 
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Although it is evident that core similarities between the fat body and adipose tissue 
exist, it is believed that adipocytes appeared during early vertebrate evolution, indicating 
that the rapid mobilization of the lipid droplet in adipocytes, otherwise known as 
lipolysis, is unique to vertebrates9. Additionally, sympathetic nervous system (SNS) 
innervation of adipose tissue is a potent regulator of lipolysis, a neural system that 
invertebrates either have a primitive form of, or do not possess at all15. 
Differences within the vertebrate subphyla exist, too. Endothermy, endogenous 
heat production, is an evolved capability that allows organisms to self-regulate in order 
to achieve appropriate physiological body temperature. Only mammals and birds are 
universally endothermic, though some species of fish are capable of endothermy. 
Shivering through muscular exertion and uncoupled oxidative metabolism that occurs in 
brown adipose tissue are examples of endothermy. These two functions are achieved 
from the mobilization of fatty acids out of energy stores located in the adipocyte and 
thus, underscores the critical importance of adipose tissue in vertebrates.  
Moreover, phasic obesity is a critical physiological behavior exhibited in mammals, 
bears for example. Similar to pathological obesity seen in humans, both arise from 
overeating. During periods of obesity, animals become hyperphagic and sometimes 
sedentary15, leading to decreased sympathetic tone in white adipose tissue (WAT) and 
increased SNS outflow to brown adipose tissue (BAT)16. However, this type of obesity is 
transient, controlled, and followed by prolonged periods of fasting15. During fasting, 
sympathetic tone in WAT increases because norepinephrine (NE) release increases in 
response to acute bouts of starvation17, causing mobilization of lipid stores into tissues 
like muscle18. Additionally, intense locomotor activity can be observed after the 
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hyperphagia, acting in concert with the fasting period, leading to weight loss15. Given 
the bouts of increased locomotor activity and fasting after prolonged hyperphagia, the 
natural cycles of obesity in wild animals never leads to diabetes or cardiovascular 
disease15, making it an ideal reference for information about structure, composition, 
neural, and endocrine activity in metabolically healthy adipose tissue. Taken together, it 
is evident that adipose tissue is critical to sustaining life, as its presence is conserved 
across the evolutionary spectrum.  
1.1.2. Adipose tissue location, type, morphology 
Adipose tissue is a complex endocrine organ that exists as subcutaneous (superficial) 
and visceral (deep) depots throughout the body8. In adult rodents, subcutaneous 
adipose tissue is divided as either anterior or posterior. Anterior subcutaneous adipose 
tissue is situated at the level of the scapulae and divided into distinct depots: 
interscapular, subscapular, axillary, and cervical. Posterior subcutaneous adipose tissue 
is formed by three depots: dorso-lumbar, inguinal, and gluteal. The dorso-lumbar and 
inguinal depots are commonly treated as one depot and referred to as inguinal white 
adipose tissue (iWAT) and thus, will be referred to as such herein. The primary visceral 
depots are contained within the abdomen and are categorized as mediastinic, 
mesenteric, perigonadal, perirenal, and retroperitoneal.  
Additionally, adipose tissue is further classified by color; brown, white, or beige  
(Fig.1.1). BAT consists of ellipsoid-shaped brown adipocytes (ranging from 15-50µm in 




Figure 1.1. Cellular morphology reveals three adipose tissue types. After a 7-day cold 
challenge (10°C), adipose depots were collected and paraffin-embedded for sectioning 
(5µm thickness). In order to visualize morphology, tissues were stained with 
hematoxylin and eosin (H&E). iBAT contains almost entirely brown adipocytes, as 
evidenced by the multilocular cells, which results in an increase in the amount of plasma 
membrane (dense pink stain) (A). B) depicts a population of white adipocytes in iWAT, 
as evidenced by the large lipid droplet (absence of stain) and the nuclei pushed to the 
perimeter of the cell (blue stain). A population of beige adipocytes was located in the 
same iWAT fat pad as the white adipocytes in (B). Beige adipocytes can be identified by 
their heterogeneous appearance. There is a presence of brown adipocytes (dense pink 
stain) as well as white adipocytes (absence of stain) interspersed amongst each other 
(C). Confocal microscopy (5x objective) was used to capture images. Both adipose 
depots (iBAT, iWAT) were sourced from the same mouse.  
 
are rich with mitochondria that contain uncoupling protein 1 (UCP1), the key molecule 
responsible for nonshivering thermogenesis (NST).  
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White adipose tissue is comprised of spherical adipocytes (ranging from 20-160µm in 
diameter depending on location) that are almost entirely occupied by a large lipid 
droplet, causing the nucleus and its few mitochondria to be located along the periphery 
of the cell (Fig. 1.1.B)8.  
Within the last decade, evidence has demonstrated that when exposed to certain 
stimuli (e.g. SNS activation), WAT has the capability to transition to acquire BAT–like 
features, otherwise known as a beige or brite adipocyte19,20. More specifically, beige 
adipocytes are located amongst WAT and are purported to derive from precursors of 
white adipocytes21, but they have a different transcriptional program than white 
adipocytes 22. Like BAT, beige adipocytes are thermogenic; they possess abundant 
mitochondria and have a multilocular lipid droplet morphology (Fig. 1.1.C)23. It should be 
noted that the cellular origin of beige adipocytes continues to be a topic of debate22,24-27. 
The relative amount of each fat tissue type is influenced by a variety of factors like: body 
size and composition, metabolic rate, eating habits, nutrient selection, and physical 
activity. To add, the amount of each tissue type influences its overall functional capacity, 
and thus, one’s overall metabolic health.  
1.1.3. Functions of adipose tissue 
BAT’s principal function is heat production through NST, a form of heat production not 
associated with muscle activity, but nevertheless burns calories. The unique 
thermogenic capacity of BAT comes from the large number of mitochondria and high 
expression of UCP1 present in brown adipocytes. UCP1 is activated by free fatty acids 
(FFAs), increasing the conductance of the inner mitochondrial membrane28 and 
because anions on FFAs cannot dissociate from UCP1, the uncoupler acts as a H+ 
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carrier, causing mitochondria to generate heat instead of ATP29. In order to regulate 
body temperature, human infants have prominent depots of brown fat that dissipate with 
age20, whilst small rodents maintain their large depots throughout their life30. Adult 
humans with increased amounts of BAT are leaner and the presence of brown fat 
counteracts obesity and metabolic syndrome in rodents20, further underscoring the 
potency of BAT.  
WAT is extensively distributed throughout the body and accumulates ectopically 
in situations of adipose dysfunction31. Not only is WAT a depot for lipid storage, but it 
also has the capacity to undergo lipolysis and control energy homeostasis through 
secretion of leptin and a host of other molecules32-35. Similar to WAT, beige adipocytes 
possess very low levels of UCP1. However, upon stimulation, UCP1 levels in beige fat 
can be induced to a level that is thermogenically functional. Shabalina et al (2013) found 
that chronic cold exposure (4 weeks at 4°C) did not result in significant differences in 
mitochondrial respiratory chain protein levels between iBAT and beige fat extracted 
from iWAT. Given the high capacity of the respiratory chain found in BAT, a similar level 
found in beige fat provides evidence for UCP1 function. Under the same conditions, 
rates of oxidative phosphorylation in mitochondria did not differ between iBAT and beige 
fat, indicating that the UCP1 expression in beige fat has an inherent potential for NST21. 
Therefore, it has been theorized that stimulating the development of beige adipocytes 





1.2. The peripheral nervous system connection to adipose end-organs 
The major growth in the field of adipose biology has revealed numerous bioactive 
peptides secreted and expressed by adipose tissue37. Most notably, the identification of 
leptin, a hormone almost exclusively secreted from adipocytes38, has validated the 
importance of adipose tissue in proper metabolic function. In 1994, Dr. Jeffrey 
Friedman’s lab identified that the voracious appetite and subsequent obesity observed 
in ob/ob mice was caused by a mutation in the gene encoding for leptin, causing an 
inability to produce the hormone39. When ob/ob mice are treated with exogenous leptin, 
significant weight loss and reversal of metabolic defects were observed40. Unfortunately, 
leptin treatment is not an effective weight loss treatment in animals or humans that 
properly encode for leptin because leptin levels are in direct proportion to adipose tissue 
mass, and can actually create leptin resistance in obese individuals40,41. Although ob/ob 
mice are only one representative model of human obesity, they are critical for studies 
that aim to understand how leptin regulates food intake, metabolism, and obesity as the 
effects of leptin resistance (or surplus of leptin) can mimic those of leptin deficiency.  
In metabolically healthy individuals, leptin functions as a metabolic signal of energy 
sufficiency41,42. Hyperleptinemia is associated with metabolic disorders. Recently, Zhao 
et al. (2019) demonstrated that reducing plasma leptin levels in the context of obesity 
recovered hypothalamic leptin sensitivity while reducing weight gain and enhancing 
insulin sensitivity43. During periods of starvation, leptin concentrations decrease, thereby 
signaling the hypothalamus to increase food intake. In contrast, when energy stores are 
fulfilled, leptin concentrations increase and signal the hypothalamus to decrease food 
intake. In addition to the extensive literature characterizing leptin’s inhibitory effect on 
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food intake, leptin also mediates energy expenditure (EE). Early work described an 
increase in body temperature and physical activity when ob/ob mice were administered 
leptin40,44. A later study attributed the leptin-induced effect on EE to the activation of 
sympathetic nerves innervating BAT, a thermogenic tissue44,45. Furthermore, leptin 
induction of UCP1 is lost after BAT sympathectomy45.   
1.3. The role of the sympathetic nervous system in adipose tissue 
In response to changes in nutritional or hormonal status, adipocytes have the unique 
capability to both accumulate and store large amounts of triglyceride (lipogenesis) within 
the lipid droplet, or hydrolyze the stored triglyceride (lipolysis) so it can be utilized as 
energy substrate in other tissues46. Since adipose tissue represents the largest energy 
reserve in the body47, the balance between lipogenesis and lipolysis largely determines 
total fat accumulation in the body. Thus, intense research interest lies in pinpointing the 
underlying mechanisms and players involved in lipogenesis and lipolysis in order to 
develop therapeutic treatments for obesity. 
1.3.1. Sympathetic regulation of brown adipose tissue 
Amongst the numerous factors that have the capacity to influence the brown adipocyte, 
NE is considered the most important and most studied. NE plays an important role in 
NST, BAT’s key function48. In order to gain further insight as to the importance of 
sympathetic innervation in BAT, researchers performed a surgical denervation to the 
interscapular brown adipose tissue (iBAT), the largest brown fat depot in the body49,50. 
Unilateral denervation of iBAT caused a significant decrease in mass and protein 
content of the iBAT, indicating that the hypertrophy and the increased thermogenic 
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capacity of brown fat induced by cold-adaptation depends entirely upon the presence of 
sympathetic innervation within the tissue49. In another experiment, researchers injected 
SR-59230A, a beta-3 adrenergic receptor (β3-AR) antagonist, which blocks NE from 
binding to the receptor and therefore, blocks sympathetically-mediated BAT 
thermogenesis. In a dose-dependent manner, as concentration of SR-59230A 
increased, the average iBAT and body temperature of the rats significantly decreased 
compared to the controls that were injected with water. These findings demonstrate that 
a profound amount of thermogenesis is provided by sympathetic stimulation51. 
1.3.2. Sympathetic regulation of white adipose tissue 
Interestingly, the SNS has emerged as a key regulator in WAT function, namely its 
action in lipolysis (Figure 1.2). Upon sympathetic activation, release of the 
catecholamine, NE, from post-ganglionic sympathetic nerve fibers innervating adipose 
tissue binds to G-protein coupled alpha- and beta-adrenoceptors located on the surface 
of adipocytes. In mice, NE predominantly stimulates β3-ARs52,53 activating adenylate 
cyclase, increasing cyclic adenosine monophosphate (cAMP), which stimulates protein 
kinase a (PKA) to phosphorylate hormone-sensitive lipase (HSL). Concurrently with 
HSL, adipose triglyceride lipase (ATGL) and monoacylglycerol (MAG) participate to 
hydrolyze the lipid droplet (triacylglycerol, TAG)54. The resulting products are three fatty 
acids and one glycerol molecule, which exit the adipocyte and enter the bloodstream. 
The FFAs are taken up by other tissues, ultimately utilized for ATP generation while the 
glycerol is taken up by the liver where it inevitably gets routed to the glycolysis 
pathway55.  
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 In fact, a substantial amount of literature has demonstrated the necessity of 
sympathetic innervation into WAT. In early work studying the SNS regulation of WAT, 
researchers postulated that the relationship between the SNS and the adrenal medulla, 
the source of catecholamine production and secretion, was crucial for the “fight or flight” 
response; raising blood glucose, mobilizing FFAs from AT, and increasing metabolic 
rate56. To the contrary, a mounting body of evidence has demonstrated that mobilization 
of FFAs requires direct sympathetic activation, opposing the idea that circulating 
catecholamines secreted from the adrenal medulla alone are sufficient56. To elaborate, 
adrenal demedullation in rats did not block NE turnover (a method used to measure 
sympathetic activation) during cold exposure57,58. Furthermore, sympathetic and 
ganglionic blockade experiments targeting the fat pad was demonstrated to inhibit the 
mobilization of lipid59,60, indicating the importance of direct sympathetic innervation. To 
add, Shi et al. concluded that when iWAT was surgically denervated, white adipocytes 
displayed a significant increase in both hypertrophy and hyperplasia, concluding that 
intact sympathetic innervation can inhibit fat pad growth and proliferation in the iWAT61.  
Although it is clear that the SNS plays a profound role in proper WAT functioning, 
it is important to realize that individuals with obesity have impaired WAT function. 
Wilfried Jänig describes that functional diseases like obesity, type 2 diabetes, and 
metabolic syndrome can be attributed to prolonged activation endured by the autonomic 
nervous system (ANS)62. Therefore, it is feasible to hypothesize that obesity diminishes 
or damages SNS innervation into the fat pad. Future strategies should attempt to 
restore metabolic function of WAT with the use of neuromodulation techniques that aim 
to increase the density of SNS innervation in adipose depots like iWAT.  
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1.4. Research focus 
Our goal was to conduct a comprehensive study demonstrating the origin of 
sympathetic innervation to the iBAT and the iWAT in the mouse. To that end, we used 
the unique combination of reporter mice, viral retrograde tracing, large-volume tissue 
clearance, and light sheet microscopy to visualize the sympathetic innervation as well 
as the identity of the pre- and postganglionic inputs of the fat pads. Indeed, in our iBAT 
innervation study, we found that postganglionic neurons emanating from the fused 
stellate/T1 sympathetic chain ganglia innervate iBAT, but also extend to T5 sympathetic 
chain ganglia. Our study is the first to systematically analyze the extent of pre-
ganglionic neurons in the intermediolateral nucleus of the spinal cord (IML) that 
innervate iBAT (level T2-T6).  
We have also utilized the previously described methodologies to map the 
sympathetic innervation of iWAT. Further, we provide insight to the direct pre- and post-
ganglionic sympathetic input of iWAT, while simultaneously presenting these findings 
with surrounding anatomical context in great detail. As a result of injecting PRV into the 
iWAT, we concluded that sympathetic nerves that originate from T12, T13, and L1 
sympathetic chain ganglia are the primary contributors supplying the iWAT depot, while 
pre-ganglionic neurons in the IML at thoracic level T8-T10 appear to be the most 
common pre-ganglionic inputs communicating to iWAT. Notably, both data sets clarify 
that iBAT and iWAT receive pre-and postganglionic input from distinct anatomical levels 
that do not overlap, which is in contrast to the previously published data63.  
Lastly, it was important to account for viral contamination. To confirm that 
injecting PRV was required for viral expression, we designed a negative control that 
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entailed dripping an equal amount of virus directly onto the fat pad. No evidence of PRV 
labeling could be detected in the sympathetic chain ganglia, dorsal root ganglia, IML, or 
celiac plexus in the negative controls. Furthermore, with observation under a 
stereomicroscope, we did not detect expression of PRV anywhere else in the abdominal 
cavity. These results demonstrate that the virus did not “leak” and randomly express 
PRV if the virus were to make surface contact with nearby structures.  
In sum, using transgenic reporter mice, retrograde tracing, whole-body tissue 
clearance, and lightsheet microscopy we present comprehensive insight to the SNS 
mapping of iBAT and iWAT in adult mice. These findings will be indispensable when 
strategizing future experiments targeting fat pads that involve the use of 











Chapter 2. Sympathetic Innervation of Interscapular Brown Adipose 
Tissue in the Mouse1 
 
2.1. Introduction 
Interest in BAT as a site for burning off excess calories in the fight against obesity flared 
up 35 years ago64,65 and returned recently after a long hiatus66,67. While it has been 
clear that brown fat thermogenesis is important for the maintenance of body 
temperature for most homeothermic animals and human infants, a significant 
contribution in adult humans has only recently been suggested by the rediscovery of 
significant BAT depots64,67-72. Besides responsiveness to photoperiod and ambient 
temperature66,73,74, BAT activity in adult humans increases after a high-calorie meal75. 
This latter finding revives Rothwell and Stock’s original idea of “Luxuskonsumption,” or 
the ability of BAT to burn off extra calories and prevent obesity76.  
In rodents, iBAT is the largest depot, with smaller depots in the mediastinum, 
along the cervical and thoracic aorta, and around the kidneys77. In humans, BAT is less 
centralized than in rodents, with significant depots in supraclavicular, neck, and 
paraspinal regions67,78,79. Based on numerous experiments with denervation of the 
interscapular pads in rodents, as well as pharmacological studies using β3-adrenergic 
agonists and blockers, the main driver of BAT thermogenesis seems to be its 
noradrenergic sympathetic innervation80-88. Furthermore, a recent study demonstrating 
                                            
1 This chapter was originally published in the Annals of the New York Academy of 
Sciences as Huesing, C. et al (2019), Sympathetic innervation of the interscapular 





increased thermogenesis by electrical field stimulation of the dorsal surface of iBAT in 
rats89 suggests that stimulation of noradrenaline release from sympathetic nerve 
terminals is required for this effect. The functional necessity of the SNS for intact BAT 
function is demonstrated by surgical and chemical denervation methods, which block or 
greatly reduce most cold-induced BAT adaptations like UCP1 induction, increased 
blood flow, higher mitochondrial density, enhanced glucose uptake, and activation of 
thyroid-activating enzymes90. 
Thus, there is an increasing need to visualize the sympathetic innervation of BAT 
efficiently to make this tissue accessible for peripheral nerve stimulation, verification of 
viral labeling extent, and specialized pharmacotherapy. Here, we identify different 
reporter mice that efficiently visualize peripheral sympathetic innervation and establish 
the use of immunohistochemical double labeling and tissue clearing for large thoracic 
specimens to identify the location and distribution of postganglionic sympathetic 
neurons innervating iBAT in the mouse using the widely-utilized pseudorabies virus 
(PRV). 
2.2. Materials and methods 
2.2.1. Animals 
Transgenic tgDbh-Cre mice (stock #: 032081-UCD,Tg(Dbh-Cre)KH212Gsat/Mmucd, 
Mutant Mouse Resource and Research Center, breeding pairs were obtained from Dr. 
Derbenev, Tulane University), TH-IRES-Cre mice (EM: 00254; B6.129×1-
Thtm1(Cre)Te/Kieg; European Mouse Mutant Archive; breeding pairs were obtained 
from Dr. Louis deLecea, Stanford University) crossed with Rosa-Tomatofl/flmice (stock 
#: 007914; B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J, Jackson Laboratories) 
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to generate TH:Tomato reporter mice. Both male and female offspring were group-
housed at a12h:12h light/dark cycle with ad-lib access to food and water unless stated 
otherwise. Animal genotypes were confirmed by PCR from tail biop-sies DNA (tgDbh-
Cre mice: transgene forward5′-AATGGCAGAGTGGGGTTGGG-3′;transgene reverse 5′-
CGGCAAACGGACAGAAGCATT-3′;TH-IRES-Cre: Cre reverse 5′-GAT-ACC-TGG-CCT-
GGT-CTG-3′; wild-type/Cre forward 5′-CAC-CCT-GAC-CCA-AGC-ACT-3′;wild-type 
reverse 5′-CTT-TCC-TTC-CTT-TAT-TGA-GAT-3′;Rosa-Tomatofl/flmice: wild-type 
forward 5′-AAG GGA GCT GCA GTG GAG TA-3′;wild-type reverse 5′-CCG AAA ATC 
TGT GGG AAG TC-3′;mutant reverse 5′-GGC ATT AAA GCA GCGTAT CC-3′;mutant 
forward5′-CTG TTC CTGTAC GGC ATG G-3′). The Pennington Biomedical Institutional 
Animal Care and Use Committee approved all animal experiments. 
2.2.2. PRV infection of the iBAT 
In Figure 1A, the experimental steps are summarized schematically. The iBAT (n=9 
mice; 7F,2M) received a unilateral injection with green fluorescent protein (GFP) 
expressing PRV (PRV-GFP, viral titer, 1×109pfu/mL, Lot #2007, 5×100 nL, kindly 
provided by the National Center for Experimental Neuroanatomy with Neurotropic 
Viruses, Pittsburgh, PA). Mice were anesthetized with isofluorane/oxygen and iBAT was 
exposed by an intrascapular incision. The virus was then injected with a pulled glass 
pipette (tip diameter∼5μm) attached to a 0.5-μLHamilton syringe. Five separate 
injections of 100 nL were distributed over the right iBAT depot, holding the pipette in 
place for 10s to prevent backflow. Injection sites were then dried with gauze to prevent 
leakage to surrounding tissue and the circulation. Mice were single-housed post viral 
infection for 72 and 96h, and then perfused and processed as described below. 
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Controls included dripping the same total amount of PRV (500 nL) onto the surface of 
the iBAT depot (n=2) or surgical (n=2) denervation of iBAT. 
2.2.3. Perfusion and fluorescence-guided dissection of relevant tissue blocks 
Mice injected with PRV were perfused at 3−4 days post viral infection. Perfusion and 
immunohistochemistry were performed as previously described91. Briefly, mice were 
deeply anesthetized with isoflurane and transcardially perfused with ice-cold 
physiological saline followed by 10% buffered formalin. 
Thoracic organs were removed and successful infection was verified with a 
fluorescent stereomicroscope (Nikon, SMZ25, Melville, NY) and only animals with 
visible sympathetic chain ganglia infection were further included in tissue dissection and 
analysis. The BAT was removed and the entire spinal cord was further cleared of 
excessive muscle mass. A laminectomy was performed to allow imaging of 
preganglionic IML neurons. The spinal cord was cut at the thoracic level T7/T8 to 
accommodate optimal imaging capacities. The tissue was post-fixed in formalin 
overnight and transferred to PBS-azide (2% sodium azide in PBS). All PRV-GFP–
infected tissue was dehydrated in methanol (20%, 40%, 60%, 80%, and 100%, 1 h 
each) and stored in 100% methanol until further processing for staining and clearing as 
described below. 
2.2.4. Immunohistochemistry and tissue clearing 
Immunohistochemical staining was performed following the method from Renier et al. 
(https://idisco.info/idisco-protocol/updatehistory/) with modifications. Briefly, after 
methanol dehydration, tissues were treated with 5% H2 O2 in methanol (MeOH) 
 17 
overnight at 4 °C (1 volume 30% H2 O2 /5 volumes methanol, ice-cold), followed by 
washes in 100% methanol for 1h and rehydrated in a series of MeOH /PBS (80%, 60%, 
40%, and 20%) for 1h each. Samples were further incubated in 1 x PBS/0.2% Triton X-
100 twice (PTx.2 solution) for 1h each and permeabilized in 400 mL PTx.2, 11.5 g 
glycine, 100 mL DMSO at 37 °C with shaking for 2 days. See Appendix B for a complete 
list of antibodies used. After that, tissues were blocked in 42 mL PTx.2, 3 mL donkey 
serum (Jackson ImmunoResearch, West Grove, PA), and 5 mL DMSO over 2.5 days at 
37 °C with shaking. Then, tissues were incubated with primary antibodies (chicken anti-
GFP [1:400], Abcam, Cambridge, MA; rabbit anti-TH [1:400], Millipore, Burlington, MA) 
in PBS with 20% Tween 20 and 10 mg/mL heparin (PTwH)/5% DMSO/3% donkey 
serum at 37 °C with shaking for at least 7 days. Following primary staining, tissue 
samples were washed in PtWH 4−5 times in 60-min increments and then incubated in 
PtwH overnight. Samples were then subjected to secondary staining in PTwH/3% 
donkey serum for 1.5 weeks. Following primary staining, tissue samples were washed 
in PtwH 4−5 times 1h or until the following day. 
Samples were dehydrated in MeOH/H2O series, incubated in                         
66% dichloromethane (DCM, SigmaAldrich, St. Louis, MO)/33% MeOH at room 
temperature, and then in 100% DCM for 15 min twice with agitating on a rocker to rinse 
out any remaining MeOH. Tissues were stored in dibenzyl ether (DBE, Sigma-Aldrich) 
until imaging. 
2.2.5. Microscopy and image processing 
Spine sample imaging utilizing both a Leica SP5confocal microscope (Leica Biosystems 
Inc., BuffaloGrove, IL) and a LaVision light sheet microscope (LaVision BioTec, 
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Bielefeld, Germany). Specimen imaging in the organic solvent required immersion of the 
microscope objective in it, which is a capability of the light sheet but not the confocal 
microscope. Therefore, we used a handcrafted chamber for the confocal microscope to 
allow safe specimen access without damaging the equipment. Overview 3D image 
stacks were generated for the spine with a dorsal view to reveal PRV labeling in the IML 
column. 3D image stacks with a ventral view revealed thoracic and lumbar sympathetic 
chain ganglia and the celiac ganglion (CG). Images of tyrosine hydroxylase (TH) and 
PRV labeling were collected for all samples. Higher magnification images were 
generated (10×) for PRV-positive sympathetic chain ganglia and the corresponding 
dorsal root ganglia (DRG), as indicated in figures, as well as for PRV-positive IML 
neurons. Note, even though confocal and lightsheet microscopy both have advantages 
and disadvantages, at this level of analysis we used both systems interchangeable and 
both systems were sufficient to obtain single-cell resolution of pseudorabies virus-
labeled postganglionic neurons. 
2.2.6. Quantitative analyses of postganglionic neurons 
Among all investigated animals with successful PRV labeling, no evidence was found 
for pre- or post-ganglionic PRV labeling beyond thoracic level T8 and T7, respectively. 
Thus, we performed the systematic analysis only for the rostral portion of the spinal cord 
(the stellate ganglion to the sympathetic chain ganglion T8). 
Overview images (5x magnification/1.0 zoom factor) showing the ventral 
(sympathetic chain ganglia) and dorsal (IML) view of the spinal cord were aligned to 
determine the thoracic levels of sympathetic chain ganglia and IML PRV labeling. We 
further investigated 10x magnification images to analyze PRV-labeled portions in more 
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detail. Individual sympathetic chain ganglia were further quantified for the number of 
PRV-labeled neurons as a measure of infection efficiency and consistency for individual 
cases. 3D images included DRG for each sympathetic chain ganglia level and allowed 
evaluation for PRV labeling of sensory cell bodies. Within sympathetic chain ganglia, we 
estimated cell counts for PRV-positive neurons in z-stack images manually with the 
Adobe Photoshop count tool (AdobePhotoshopCS6, SanJose,CA), and an automated 
3D analysis of cell counts utilizing the Imaris 9.2 spot counting feature (Bitplane AG, 
Concord,MA). 
2.3. Results 
2.3.1. Whole body in situ imaging and dissection of sympathetic nervous system 
components using TH:Tomato reporter mice 
 
In order to guide the dissection of the thoracic specimen that would retain components 
of the SNS, we wanted to capitalize on the powerful ability of reporter gene expression. 
Most reporter lines are well characterized for their expression profile in the central 
nervous system (CNS), while reporter expression in peripheral nerves remains 
unexplored. We found that knock-in TH:Tomato mice and transgenic Dbh:Tomato mice 
both showed strong fluorescence in noradrenergic nerves. After formalin fixation and 
removing the viscera, the bilateral sympathetic chain ganglia could be identified using a 
fluorescent stereomicroscope with a long working distance (Fig. 2.1.A). Knock-in 
TH:Tomato mice (Fig. 2.1.B) showed stronger fluorescence compared to transgenic 
Dbh:Tomato mice (Fig. 2.1.C), but both mouse lines showed bright fluorescence, 





Figure 2.1. Overview of experimental design, dissection technique, and whole body 
tissue clearing. (A) Flow diagram of experimental design. (B and C) Ventral views of 
eviscerated, perfused TH:Tomato mouse (B), Dbh:Tomato mouse (C) using 
stereomicroscope. (D) Ventral view of eviscerated, perfused wild-type mouse 96 h post-
PRV-GFP injection into the right iBAT pad using stereomicroscope. Note labeling of 
right, but not left sympathetic chain ganglia. (E) Confocal microscope image of the 
whole upper body of a mouse after iDISCO immunohistochemistry with TH and tissue 
clearing. Note labeling of the bilateral sympathetic chain, neck nerves, and brain areas. 
TH, tyrosine hydroxylase; DBH, dopamine beta-hydroxylase; PRV, pseudorabies virus; 
GFP, green fluorescent protein; SG, stellate ganglion; T1−T7, ganglia for thoracic levels 
1−7. 
 
In contrast, our initial attempts using transgenic TH:Tomato mice (B6.Cg-
7630403G23RikTg(Th-cre)1Tmd /J, Stock# 008601) showed only sporadic fluorescent signal 
with only one or two Tomato-positive cells per thoracic sympathetic ganglia (data not  
shown). Thus, in our hands, knock-in TH:Tomato mice and transgenic Dbh:Tomato 
mice were most useful to visualize sympathetic chain ganglia, and associated nerves, 
and to clean ganglia of obscuring tissues (e.g., ganglia adipose tissue). Sympathetic 
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chain ganglia can be visualized without reporter gene expression, but the 
celiac/mesenteric ganglia complex is not visible without fluorescent labeling and 
abdominal chain ganglia are easily confused regarding to their thoracic and lumbar 
levels without fluorescent guidance specifically for the untrained experimenter. 
2.3.2. Clearing of large tissue blocks reveals 3D anatomy of sympathetic chain 
and other components of the SNS 
 
Earlier work in embryos or newborn mice has used whole body clearing techniques to 
visualize sympathetic chain ganglia; however, this technique has not been adapted to 
substantially larger adult mice with excessive muscle and adipose tissue mass. 
However, recent histological advances have promoted tissue clearance for a larger 
specimen like the brain and human embryos92, suggesting that these techniques might 
also be suitable to visualize sympathetic chain ganglia in adult animals. We generated 
tissue blocks that contained specific components of the SNS of adult mice and 
subjected them to a modified iDISCO clearing protocol with immunohistochemistry for 
TH and other markers. This revealed for the first time in adult mice the undisturbed 
three-dimensional structure of the bilateral sympathetic chain and intercostal nerves, as 
well as adrenergic nerves and neurons in the neck and brain (Fig. 2.1.E and 
Supplementary Video S1, online only). Specifically, using classical or light sheet 
confocal microscopy, the individual anatomy of the stellate to T13 and lumbar 
sympathetic chain ganglia and interconnecting nerve strands were revealed in their  
three-dimensional space on a background of rib and vertebral column structure, which 
did not completely clear. 
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Figure 2.2. Ventral overview of sympathetic postganglionic ganglia innervating iBAT in 
the mouse as shown by two examples with unilateral PRV injections in the right iBAT  
pad (A and B). Confocal microscope images of tyrosine hydroxylase (TH) (A and B), 
PRV with GFP expression (PRV-GFP) (A’ and B’) and merged images (A” and B”) from 
iDISCO-processed whole tissue blocks. Note retrograde labeling of the right stellate/T1 
ganglion, as well as T2−T4 in example A and T2−T6 in example B. 
 
2.3.3. Pseudorabies virus mapping of iBAT-innervating neurons in sympathetic 
chain ganglia and spinal cord 
PRV has been widely used to identify the ANS innervation of peripheral tissues and is 
the retrograde tracer of choice93. We injected GFP-conjugated PRV unilaterally into the 
right iBAT pad. Our focus was on first- and second order neurons only (pre- and 
postganglionic neurons), so that the survival time after virus injections was kept short 
with 3−4 days. Labeling in the SG and upper thoracic sympathetic chain ganglia on the 
ipsilateral injection side could be seen in fixed and eviscerated whole animal 
preparations using a fluorescence stereomicroscope (Fig. 2.1.C), which guided 
dissection as above. After iDISCO clearance with the immunohistochemical 
enhancement of viral GFP and TH, many more details became visible with classical and 
light sheet confocal microscopy (Figs. 2.2 and 2.3).  
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Figure 2.3. Postganglionic sympathetic neurons innervating iBAT in the mouse. 
(A and B) Light sheet microscope images of two examples of retrogradely PRV-labeled 
postganglionic sympathetic neurons in the fused right stellate/T1 ganglion after 
unilateral PRV injections into the right iBAT pad. Inset shows retrogradely PRV-labeled 
(green) and unlabeled (red) neurons at higher magnification (asterisks depict examples 
of colocalized neurons). (C–H) Confocal microscope images of individual sympathetic 
chain ganglia at thoracic levels T2−T7 in the same mouse for which the stellate ganglion 
is shown in (B). Note strong labeling in T2−T4 and much weaker labeling in T5 and T6 
ganglia. TH, tyrosine hydroxylase; PRV, pseudorabies virus; SG, stellate ganglion; 
T1−T7, ganglia for thoracic levels 1−7. 
 
Specifically, there was strong labeling not only in the caudal portion of the SG, 
but also in the thoracic chain ganglia from T1 (typically fused to the SG) to T5, and in 
some cases scattered labeling up to T7. Labeling was limited to the ipsilateral side of 
the injection, even though we observed rare cases of bilateral labeling, likely due to 
accidental injection into the adjacent and merged left iBAT section. Labeling in the T5 to 
T7 ganglia became increasingly sparse. Higher magnification images clearly revealed 




Figure 2.4. Controls for nonspecific labeling. (A and B) Light sheet microscope images 
of the fused right stellate/T1 ganglion showing the absence of PRV-labeled neurons 
(green) in mouse with PRV injections into surgically denervated right iBAT pad. (A’) 
Same ganglion with TH fluorescence (red) to show the outline of the ganglion. The 
sympathetic innervation (TH labeling) is degraded in the denervated iBAT pad, in 
contrast to the intact iBAT pad (B). (C) Light sheet microscope image of a mouse with 
successful PRV labeling in sympathetic chain ganglia shows a complete absence of 
PRV labeling in the celiac ganglion (CG). (D–G) Confocal microscope images of a 
mouse with successful PRV labeling in sympathetic chain ganglia show sparse PRV 
labeling (green dots) in T3-DRG (D), T4-DRG (E), T5-DRG (F), and T6-DRG (G). TH, 
tyrosine hydroxylase; PRV, pseudorabies virus; SG, stellate ganglion; DRG, dorsal root 
ganglion; T1−T7, ganglia for thoracic levels 1−7. 
 
In addition, PRV-labeled nerve fibers within intercostal nerves and ganglia connecting 
nerve strands could be discerned on the background of TH-positive nerves. 
Importantly, injection of the same viral dose in mice with prior surgical iBAT 
denervation (Fig. 2.4.A, B), or dribbling it over the surface of iBAT (data not shown), did 
not result in any discernible labeling in any sympathetic chain ganglia.  
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TH labeling also revealed the location of the DRG as well as the paravertebral ganglia 
and we inspected these ganglia for PRV-labeled neurons.  
We found no indication of PRV labeling in paravertebral abdominal ganglia, such 
as the celiac (Fig. 2.4.C) and splanchnic nerves, even though a few iBAT projecting 
DRG neurons were identified with PRV labeling (Fig. 2.4.D−G). 
Quantitative cell count analysis of nine successful PRV injections revealed that 
about half of PRV-labeled neurons (approximately 789 cells) were located in the fused 
stellate/T1 ganglion and the other half was distributed over T2−T5 (approximately 723 
cells, Fig. 2.5, Appendix B). However, the number of labeled neurons in the stellate/T1 
ganglia varied widely between animals, indicating either a biological variation or 
incomplete labeling.  
To map the preganglionic neurons in the spinal cord that innervate iBAT, light 
sheet microscopy was performed on cleared tissue blocks from seven mice containing 
the spinal cord and the sympathetic chain (Fig. 2.6.A). PRV labeling in the IML column 
of the spinal cord was found between rostrocaudal levels T2–T8 (Fig. 2.6.B). None of 
these seven mice showed preganglionic labeled neurons at the level of the stellate/T1 
ganglia or beyond T9, all seven mice showed labeling at levels T2−T6, and labeling 
from T7 to T8 was found in a subset of animals (n=6,5 respectively). Thus, the 
representation of preganglionic neurons innervating iBAT is slightly shifted to more 










Figure 2.5. Quantitative distribution of sympathetic postganglionic neurons innervating 
iBAT in the mouse. Mean ± SEM of number of retrogradely labeled neurons in mice (n = 
9) unilaterally injected with PRV into the left iBAT pad. Note that about half the 
retrogradely labeled neurons are located in the fused stellate/T1 ganglion and the other 
half is distributed over T1−T5 ganglia. 
 
2.4. Discussion 
Brown fat thermogenesis is an evolutionarily conserved mechanism to maintain body 
temperature in mammals and has the potential to convert surplus energy into heat for  
better energy balance control in an environment of plenty76,94. In addition, BAT may be 
the source of factors and hormones that play important roles in metabolic health91,95-97.  
Because sympathetic drive is required for optimal BAT function98,99, identification of the 
sympathetic pre- and postganglionic neurons selectively innervating BAT is important. 
Here, we combine classical pseudorabies retrograde tracing with transgenic mouse 
models, whole tissue clearing, and confocal light sheet microscopy to show the specific 
distribution of sympathetic postganglionic neurons innervating the iBAT in the mouse. 
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We identified suitable reporter mice to guide initial dissection of large tissue blocks 
containing the critical components, which greatly increases confidence in anatomical 
dissection and sectioning techniques. We further adapt iDISCO methods to 
immunohistochemically stain and perform tissue clearance of the entire spinal cord and 
sympathetic chain in the adult mouse. This approach is able to visualize the entire SNS 
and its major components undisturbed in situ, and greatly facilitates the unbiased and 
transparent evaluation of pre- and postganglionic contribution to iBAT innervation. 
Contrary to findings in the rat100,101 and Siberian hamster102, we found iBAT-innervating 
sympathetic postganglionic neurons not just in the SG but also in the T2−T5 
sympathetic chain ganglia. Interestingly, within the SG, the rostral pole is suspiciously 
void of neurons innervating iBAT. The rostral pole is known to harbor postganglionic 
neurons that innervate the heart103,104. In contrast, the more caudal portions of the SG 
together with the T1, T2, T3, T4, and T5 chain ganglia are densely packed with iBAT-
innervating neurons. Future studies will further investigate how the sympathetic nerves 
leaving these individual ganglia relate to the organization of end-organ iBAT innervation. 
Importantly, we did not find any iBAT-innervating postganglionic neurons in the 
lower sympathetic chain ganglia as reported for the Siberian hamster63. This is 
consistent with the overall development of sympathetic innervation that clearly 
dissociates the origin of sympathetic innervation in anterior (thorax and forelimbs), 
posterior (hind limb), and abdominal (situ) sites105, and classic views of autonomic 
innervation100. A few PRV-labeled neurons were found in DRG, and it is not clear 
whether these are true sympathetic efferent neurons or inadvertently anterograde 




Figure 2.6. Location of sympathetic preganglionic neurons innervating iBAT and 
schematic diagram of sympathetic outflow pattern to iBAT in the mouse. (A and A’) Light 
sheet microscope image through spinal cord showing the location of preganglionic 
neurons (green) on the right side of the intermediolateral column (A), and merged image 
of PRV and TH (A’) in a mouse with unilateral injection of PRV into the left iBAT pad. (B) 
Semiquantitative assessment of location of postganglionic neurons in the spinal cord 
relative to the rostrocaudal level. Note the caudal-ward shift in representation with no 
preganglionic neurons at the level of the fused stellate/T1, T2, and T9 sympathetic 
chain ganglion. (C) Schematic diagram depicting the organization of sympathetic 
outflow to iBAT in the mouse. IML, intermediolateral column of the spinal cord. 
 
Given the very small number of these neurons, they are not likely to be of major 
physiological importance. Our analysis of preganglionic neurons in the spinal cord is in 
general agreement with studies in the rat100,106 and Siberian hamster63, which all report 
the SG as a major contribution to the sympathetic innervation of the iBAT. However, our 
data highlight the regional distribution of PRV labeling within the SG and the lack of 
PRV labeling in the dorsal pole. Furthermore, we clarify that thoracic ganglia from the 
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stellate until T5 significantly contribute to iBAT innervation, with scattered PRV labeling 
in T6/T7 and no contribution was observed below T8 chain ganglia, contrary to a report 
by Nguyen et al63. We also clarified that the prevertebral CG did not innervate iBAT, 
which has been recently suggested as the main innervation site of adipose tissue107. 
Our study is also the first to systematically investigate the anatomical extent of 
preganglionic iBAT innervating neurons in the IML (levels T2–T6). 
 Our study demonstrates the usefulness and points out some caveats of 
genetically altered mouse models for the analysis of ANS functional anatomy that 
should be very helpful for other studies. The TH-IRES-Cre knock-in and the transgenic 
DbhCre mice were both useful reporter driver in the SNS, while the transgenic TH-Cre 
mouse resulted only in sporadic cell bodies with reporter expression throughout the 
thoracic chain ganglia, which requires consideration when choosing Cre-driver lines for 
studies in peripheral sympathetic nerves. However, with appropriate Cre-driver lines, 
the red fluorescent signal in the reporter mice was strong enough to guide dissection of 
any component of the SNS in fresh or formalin perfused preparations under a 
fluorescent stereomicroscope. Other methods that have been used in the past are IP 
injections of Fluorogold108, which label all neurons of the peripheral nervous system 
(sympathetic, parasympathetic, and sensory) in rats and mice108,109, but genetic 
approaches hold promise for a better distinction of sympathetic, parasympathetic, 
sensory, and enteric nervous system components and do not require dissection under 
harmful UV light. 
 Our study also highlights that immunohistochemical staining and tissue clearance 
protocols are successful in adult animals with excellent resolution for the peripheral 
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nervous system and greatly enhance the rigor and transparency of analyzed anatomical 
levels. With the ascent of neural modulation devices and therapies110-113, it will be 
important to provide detailed, complete, and specific functional maps of peripheral 
nervous systems. To this end, analysis of large tissue blocks allowing complete spatial 
representation of all nerves and ganglia vis-à-vis specific target organs will be 
indispensable. The methodology described here should enable high-resolution 3D 
imaging of sympathetic and parasympathetic innervation of other important target 
organs, such as WAT, gut, pancreas, liver, kidneys, spleen, the urogenital tract, and the 
respiratory system. 
 One potential limitation of using mice and other small mammals as models to 
gain basic information on the functional anatomy of the ANS is the possibility of 
significant differences from humans. Specifically, comparisons of SNS innervation of 
BAT between rodents and humans are complicated by the fact that in humans it 
appears to be located and distributed quite differently than in rodents. Instead of the 
prominent iBAT pad in rodents, the most important accumulation of BAT in humans is 
supraclavicular, with additional depots in the neck and along the spinal cord 
vertebrae66,67. Even though the different distribution will likely not affect the functional 
importance of BAT per se, future studies in mice to modulate sympathetic iBAT function 
are important approaches to understanding metabolic dynamics in humans. 
 In conclusion, using transgenic TH-IRES-Cre mice, whole tissue clearing, and 
confocal/light sheet microscopy, we provide a complete map of SNS innervation of the 
mouse iBAT depot that shows the location of postganglionic sympathetic neurons not 
confined to the SG, but also the first several sympathetic chain ganglia. 
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Chapter 3. Sympathetic Innervation of Inguinal White Adipose Tissue 
in the Mouse 
3.1. Introduction 
Historically, WAT was largely considered a storage depot for excess energy114. 
However, given the increasing number of obese individuals plagued with metabolic 
syndrome, and the associated risk for life-threatening comorbidities like type 2 diabetes, 
cancer, and cardiovascular disease115, intense research over the last decades has 
highlighted a more detailed picture of the sophisticated structures within adipose tissue. 
Mature adipocytes co-exist with connective tissue, stromovascular cells, immune cells 
as well as nerve fibers and terminals; all of these are involved in endocrine crosstalk 
within the tissue and across other organs41.   
Just as excess adipose tissue poses clear health risks, the lack of adipose 
tissue, lipodystrophy, also leads to severe metabolic dysfunction, like liver steatosis and 
insulin resistance116. One of the main functions of adipocytes is to switch between 
energy storage in times of excess through lipogenesis and fat storage and serving as an 
energy source via lipolysis to provide energy during periods of low food intake (e.g. 
sleep, starvation). Since the sympathetic nervous system plays a critical role for the 
induction of lipolysis in adipocytes90,117,118, it is a good candidate for obesity 
interventions.  
Previous studies have used diverse tracing strategies in various animal models 
to identify the origin of sympathetic neurons that innervate the adipose tissue. In 
Siberian hamsters, the retrograde tracer, fluorogold was injected into iWAT and 
identified labeled cell bodies in the abdominal sympathetic chain ganglion T13119.  
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Later studies used the transsynaptic retrograde tracer, pseudorabies virus, in rats and 
showed labeling in the abdominal sympathetic chain ganglia T13 and L1100. Conversely, 
a retrograde tracing study with cholera toxin b conducted in mice suggested that iWAT 
receives sympathetic inputs from the CG107.  
Given these inconsistent findings and the increased interest to target the 
peripheral nervous system with novel molecular genetic tools100,107,120-122, the mouse will 
likely be the model of choice to target sympathetic innervation of iWAT. However, the 
mouse has not been a preferred model for dissection of the peripheral nervous system 
due to its small size. Published literature regarding the organization of the SNS in 
rodents is typically available from rats123. Yet, in order to apply novel molecular-genetic 
and viral tools in the peripheral nervous system, the mouse is the model of choice due 
to the abundant availability of cre-driver and floxed mouse lines.  
In this study, we aimed to develop a method that allows for a high level of 
scientific rigor and transparency when studying the origin of sympathetic innervation of 
iWAT in male and female mice. In a recent study, we adapted the tissue clearance and 
immunolabeling methodology, iDISCO92, to clear the entire spinal cord (SC) and 
associated peripheral ganglia in the thorax and abdomen122. This technique allowed for 
high-resolution imaging of the SNS within the abdomen, all the while leaving the 
sympathetic chain ganglia (SChG) largely intact and undisturbed. In this study, we 
combined whole body iDISCO with the retrograde transsynaptic tracer PRV to identify 
pre- and postganglionic sympathetic inputs to iWAT. We further include anatomical 
dissection techniques in reporter mice to provide a detailed anatomical map for the 
sympathetic innervation of iWAT.  
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Our PRV study clarifies the origin of postganglionic iWAT innervation from SChG 
T12-L1 and preganglionic inputs from the SC levels T7-T10 in the mouse. We show that 
the lateral cutaneous rami continue from iWAT to the skin, while fine nerves containing 
sympathetic axons branch off to the dorsolumbar portion of iWAT. Another major 
innervation is provided by the anterior and lateral femoral cutaneous nerves to the 
inguinal portion of iWAT. Our study may serve as a comprehensive map for future 
experiments that employ virally-driven neuromodulation techniques in adipose tissue for 
rigorous and transparent verification of virus infection.  
3.2. Materials and methods 
3.2.1. Animals 
TH-IRES-Cre mice (EM: 00254; B6.129X1-Thtm1(Cre)Te/Kieg; European Mouse Mutant 
Archive; breeding pairs were obtained from Dr. Luis de Lecea, Stanford University) were 
crossed with Rosa-EGFPfl/fl reporter mice (B6;129S4-
Gt(ROSA)26Sor<tm9(EGFP/Rpl10a)Amc>/J, Stock# 024750, Jackson Laboratory, Bar 
Harbor, ME) or Rosa-Tomatofl/fl mice (stock #: 007914; B6.Cg-Gt(ROSA)26Sortm14(CAG-
tdTomato)Hze/J, Jackson Laboratories, Bar Harbor, ME) to generate TH:EGFP or 
TH:Tomato reporter mice. Animal genotypes were confirmed by PCR from tail biopsies 
DNA (TH-IRES-Cre: Cre reverse 5’-GAT-ACC-TGG-CCT-GGT-CTG-3’; wild-type/Cre 
forward 5’-CAC-CCT-GAC-CCA-AGC-ACT-3’; wild-type reverse 5’-CTT-TCC-TTC-CTT-
TAT-TGA-GAT-3’; Rosa-EGFPfl/fl mice: wild-type forward 5’-AAG GGA GCT GCA GTG 
GAG TA-3’; wild-type reverse 5’-CCG AAA ATC TGT GGG AAG TC-3’; mutant forward 
5’-ATT GCA TCG CAT TGT CTG AG-3’; mutant reverse 5’-CCG AAA ATC TGT GGG 
AAG TC-3’; Rosa-Tomatofl/fl mice: wild-type forward 5’-AAG GGA GCT GCA GTG GAG 
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TA-3’; wild-type reverse 5’-CCG AAA ATC TGT GGG AAG TC-3’; mutant forward 5’-
CTG TTC CTG TAC GGC ATG G-3’; mutant reverse 5’-GGC ATT AAA GCA GCG TAT 
CC-3’;). Both male and female mice were used in all experiments and all animals were 
group-housed at a 12h:12h light/dark cycle with ad lib access to food and water unless 
stated otherwise. The Institutional Animal Care and Use Committee approved all animal 
experiments.  
3.2.2. Fluorescence-guided dissection of tissue 
We initially performed anatomical dissections in order to clarify the overall organization 
of the lower thoracic and upper abdominal sympathetic nervous system as well as iWAT 
innervation. We used TH:GFP (n=1) and TH:tomato reporter (n=6, 3 males, 3 females; 
ranging from 6 to 20 weeks of age) lines for dissections under a fluorescent 
stereomicroscope (Nikon, SMZ25, Melville, NY). Mice were euthanized with an 
overdose of CO2 and blood was removed by cardiac perfusion with saline. Thoracic and 
abdominal organs were removed and images of the pre- and paravertebral structures 
were taken for documentation. In some cases, we carefully removed the adipose tissue 
that surrounds all sympathetic ganglia (“ganglia fat”) to enhance visibility and imaging of 
abdominal ganglia. We further identified and documented major innervating nerves and 
their origin by dissection under the fluorescent stereomicroscope. In some cases we 
used TH:tomato mice to enhance visibility of fine nerves.  
3.2.3. PRV infection of iWAT 
Mice (ranging from 6-15 wks old) were anesthetized with isoflurane/oxygen. A lower 
back incision was extended laterally on the right hindleg to reveal an adequate amount 
of iWAT sufficient for injection. Ten individual injections (each 100 nL, n=2 or 200 nL, 
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n=11) were distributed across the right iWAT depot with green fluorescent protein 
expressing PRV (PRV-GFP, viral titer, 1x109 viral molecules/mL, Lot #2007, kindly 
provided by the National Center for Experimental Neuroanatomy with Neurotropic 
Viruses; Pittsburgh, PA). Virus was injected with a beveled Hamilton® syringe (Model 
7002 KH SYR, Reno, NV). Upon each injection, the syringe was held in place for 30-40 
seconds to prevent backflow. Injection sites were dried with a cotton swab to mitigate 
leakage to surrounding tissue and circulation. Mice were single-housed post-viral 
infection for 96 hours. Note, our goal was to use minimal infection times, and we tested 
10x100nl injection with different incubation times of 72 hrs (n=9) and 96 hrs (n=5), with 
no infection at 72 hrs and only 2 successfully infected animals at 96 hrs. Doubling the 
viral injection volume at 96 hrs incubation time increased the rate of successful 
infections (as observed under the dissecting microscope, 11/13). Control animals 
involved dripping the same total volume of PRV-GFP (1 µL, n=1 or 2 µL, n=4, 96 hrs 
incubation) onto the surface of the iWAT depot.  
Perfusion and immunohistochemistry were performed as previously described122. 
Mice were deeply anesthetized with an overdose of isoflurane, followed by a 
transcardiac syringe perfusion with ice-cold physiological saline, then 10% neutral 
buffered formalin (Fisher, Passaic, New Jersey). Thoracic and abdominal organs were 
removed, which allowed for verification of successful infection when viewed with a 
fluorescent stereomicroscope (Nikon, SMZ25, Melville, NY). Only mice with visible 
sympathetic chain ganglia infection were included in further tissue dissection and 
analysis of sympathetic chain ganglia (n=13, 6 females, 7 males), intermediolateral 
nucleus of the spinal cord (IML) (n=11, 4 females, 7 males), dorsal root ganglia (DRG) 
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(n=13, 6 females, 7 males) and CG (n=8, 5 females, 3 males). The iWAT was removed 
for individual processing and excessive muscle mass was dissected from the spinal 
cord. A laminectomy was performed in order to image sympathetic preganglionic 
neurons. The spine and spinal cord were cut in half (roughly at the level of ribs 7 to 9) to 
accommodate the imaging capacity of both the light sheet and confocal microscope. 
Then, the tissue was post-fixed overnight in formalin, and stored in PBS-azide (0.02% 
Na-azide in PBS) 4°C until iDISCO processing.  
3.2.3. Immunohistochemistry and tissue clearing 
Immunohistochemical staining was performed following the iDISCO method from Renier 
et al (https://idisco.info/idisco-protocol/update-history/) with modifications. Tissues were 
dehydrated in a series of Methanol (MeOH)/H2O mixtures (20%, 40%, 60%, 80%, 
100%), then incubated overnight in a 66% dichloromethane (DCM) and 33% MeOH 
solution on a rocker (Southwest Science, model SBT30, Trenton, NJ). Tissues were 
treated with 5% H2O2 in MeOH overnight at 4°C. Following overnight incubation, 
samples were rehydrated in a series of 1hr MeOH/H2O washes, then washed in PTx.2 
solution (0.2% TritonX-100 in PBS). Samples were incubated in permeabilization 
solution (400mL PTx.2, 11.5g glycine, 100mL DMSO), followed by incubation in 
blocking solution (42 mL PTx.2, 5 mL DMSO, 3 mL NDS) at 37°C for two days in a 
shaking incubator (Corning LSE Product #6790, Corning, NY). Then, tissues were 
incubated with primary antibodies (chicken anti-GFP [1:400], Abcam, Cambridge, MA; 
rabbit anti-TH [1:400], Millipore, Burlington, MA; CD31/PECAM-1 [1:300], Novus 
Biologicals, Littleton, CO) in primary incubation solution (92 mL PTwH, 5 mL DMSO, 3 
mL NDS) on a shaking incubator at 37°C for at least seven days. Following primary 
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staining, tissues underwent five, 60 minute washes in PTwH (1mL of 10mg/mL heparin 
stock solution, 2mL Tween-20, QS to 1L with PBS) then subjected to secondary staining 
(AlexaFluor 647 donkey anti-chicken [1:300], AlexaFluor 555 donkey anti-rabbit [1:300], 
Jackson ImmunoResearch, West Grove, PA, AlexaFluor 488 donkey anti-goat [1:300], 
ThermoFisher Scientific, Waltham, MA) in secondary incubation solution (PTwH with 
3% NDS) for at least seven days at 37°C on a shaking incubator. Once labeling was 
confirmed, samples underwent the same PTwH wash step, then an additional round of 
MeOH dehydration (both washes described above). Tissues were incubated in 100% 
MeOH overnight and then submerged in 66% DCM/33% MeOH solution for three hours. 
Once completed, the samples underwent two, 100% DCM washes, and were then 
placed in dibenzyl ether (DBE), an organic solvent for at least three hours at room 
temperature for clearing 
(https://www.protocols.io/private/B7569F5C0050B3198C8BBC721EC210BC). 
3.2.4. Microscopy and image processing 
A Leica SP5, SP8 X (Leica Biosystems Inc., Buffalo Grove, IL), or Ultramicroscope II 
(LaVision BioTec, Bielefeld, Germany) were used to image all relevant structures. To 
allow for confocal imaging of DBE-cleared tissues, a chamber was manufactured in-
house. 3-D overview images were generated of the spine and spinal cord in order to 
reveal PRV labeling in preganglionic sympathetic neurons (in the IML and medially) and 
DRG. The spine was repositioned with the ventral side up to allow for optimal imaging of 
thoracic and lumbar sympathetic chain ganglia, as well was the celiac ganglion. 
Lightsheet imaging was performed with a zoom factor of 0.63x or 1.6x (specified in 
figure captions). Images of TH and PRV labeling were collected for all samples, while 
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CD31 staining was not performed for all samples. Images from the far-red fluorescent 
channel were pseudocolored as green. Additionally, higher magnification (10x/0.40 NA) 
confocal images captured of PRV-positive sympathetic chain ganglia, their 
corresponding DRG, and PRV-positive preganglionic cell bodies. 
3.3. Results 
3.3.1. TH-IRES-cre/tomato mice reveal the organization of pre- and paravertebral  
ganglia in the thoracic and abdominal cavities 
 
We aimed to visualize and document the overall organization of the thoracic and 
abdominal sympathetic nervous system in adult mice and utilized cre-driver mice for the 
sympathetic marker tyrosine hydroxylase (TH), to express the reporter genes EGFP-
L10a (TH:EGFP mice) or tdTomato (TH:tomato mice). The ribosomal protein L10a 
targets green fluorescent protein (EGFP) expression to the cell body, so that TH:EGFP 
mice show strong labeling of cell body containing paravertebral ganglia (sympathetic 
chain ganglia) and prevertebral ganglia (celiac, suprarenal, aorticorenal and superior 
mesenteric ganglia); but no labeling in nerve fibers (Fig. 3.1.A,A’). In contrast, the 
cytoplasmatic tdTomato expression labels cell bodies and nerve fibers, revealing the 
connectivity of sympathetic chain and celiac complex in TH:tomato mice (Fig. 3.1.B,B’). 
In the mouse, the splanchnic nerve consistently branched off at the level of the 
sympathetic chain ganglion T12 and the elongated interganglionic strands between T12 
and T13 (piercing through the diaphragm) served as a prominent landmark to identify 
upper abdominal chain ganglia T13, and lumbar ganglia L1-L3 (Fig. 3.1.B). Abdominal 
chain ganglia required careful dissection to allow visualization for imaging (Fig. 3.1.B) 
as overlaying adipose tissue often obscured or blocked the fluorescent signal (Fig. 3.1.A 
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ganglia caudal to T8 not visible). To fully visualize the abdominal chain ganglia, the 
celiac-superior mesenteric complex was moved rostral in Fig. 3.1.B, while the 
undisturbed view of the celiac complex is shown in Fig. 3.1.B’ with further details of the 
aorticorenal ganglia and splanchnic nerves. 
 
3.3.2. Large volume tissue clearance reveals 3-D anatomy of SNS 
Tissue clearing is a well-established technique used to make an otherwise deep, 
opaque sample optically transparent to improve anatomical analysis. In 2014, Renier et 
al. modified the existing 3DISCO clearing protocol to allow the use of 
immunofluorescence labeling in large solvent-cleared tissues 92. We modified the 
iDISCO method to perform whole body histological staining for tyrosine hydroxylase 
peptide (TH-peptide) and tissue clearing in adult mice, allowing for remarkable 
visualization of sympathetic chain ganglia and their physical connections, as well as fine 
innervation structures of the celiac-superior mesenteric plexus (Fig. 3.1.C). We also 
note that this provides unparalleled anatomical detail and context for transparent and 
rigorous reporting. Furthermore, TH-peptide immunostaining is a more reliable marker 
of the sympathetic nervous system compared to direct TH-cre driven reporters. During 
early development, tyrosine hydroxylase is transiently expressed in cholinergic 
parasympathetic neurons124, meaning that parasympathetic neurons may also be 
labeled in TH-reporter mice with TH-cre induced reporter expression throughout 
development. Fig. 3.1.C clearly demonstrates TH-peptide staining in iDISCO-cleared 




Figure 3.1. Ventral views of sympathetic chain and prevertebral ganglia as seen under 
the fluorescence dissecting microscope (A-C) and in the light sheet microscope after 
iDISCO processing (D). A, A’. TH-EGFP reporter mouse (male, 8 weeks old, 0.5x 
objective) with ventral view of the sympathetic chain ganglia (T4 to T8) and abdominal 
prevertebral sympathetic ganglia (celiac superior mesenteric complex) at low 
magnification. Note, the lower sympathetic chain ganglia caudal to T8 are obscured by 
overlying fat tissue. The celiac superior mesenteric complex depicts the fused celiac 
and superior mesenteric ganglia as well as the left suprarenal, the left aorticorenal 
ganglia (A’) B. B’. TH-tomato mouse (male, 12 weeks old, 0.5x objective) with ventral 
views of lower thoracic sympathetic chain ganglia (T10 to T13) and upper lumbar 
sympathetic chain ganglia L1 to L3. The lumbar sympathetic chain ganglia can be seen 
after moving the overlying prevertebral ganglia to the side.  
(fig. cont’d) 
 41 
In B’ the celiac superior-mesenteric complex is seen undisturbed, showing several 
details, e.g. splanchnic nerves and aorticorenal ganglion. Note several non-specifically 
labeled structures such as ribs and muscle fibers. C. Light sheet microscope extended 
focus view of cleared tissue block (iDISCO, 1.6x zoom factor) with tyrosine hydroxylase 
(TH-peptide) immunohistochemistry from a 12 weeks old, male mouse, showing the 
lower thoracic and upper lumbar chain ganglia, together with the overlaying celiac-
superior mesenteric complex and connecting nerves. Note the detailed view of lower 
sympathetic chain ganglia, greater splanchnic nerves entering suprarenal and celiac-
superior mesenteric ganglionic complex. Also note the left aorticorenal ganglion and 
intermesenteric plexus. A long interganglionic strand links sympathetic chain ganglia 
T12 and T13 through the diaphragm. 
 
3.3.3. iWAT is innervated by postganglionic neurons located in sympathetic chain  
ganglia T12, T13, L1 
We aimed to clarify the origin of sympathetic innervation of iWAT using iWAT-derived 
labeling with fluorescent PRV (PRVGFP) and iDISCO TH-peptide and GFP double 
staining. These methods provide a comprehensive analysis of overall sympathetic 
structures and their according labeling with PRV. We chose a minimal PRV infection 
time that was long enough to allow consistent labeling of sympathetic chain ganglia 
(4days, Fig. 3.2.A), but was too short to label supraspinal sympathetic premotor 
neurons (e.g. raphe pallidus). Under these conditions, labeling was restricted to post- 
and preganglionic neurons and spinal interneurons.  
Light sheet and confocal microscope imaging allowed for three-dimensional 
visualization and analysis of the entire thorax and abdomen. Among the 13 analyzed 
animals (6 females, 7 males) with successful PRV labeling in sympathetic chain ganglia, 
we observed consistent labeling in ipsilateral sympathetic chain ganglia T12-L1 
(Fig.3.2.B-D), even though some variability was observed for individual cases showing 
labeling in T7-T9 (1/13), T11 (3/13) and L2 (3/13) (Figure 3.2.D; Appendix C). No tracer 
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labeling was detected in contralateral ganglia. Additionally, we could not find any 
obvious differences between male and female mice at any level of iWAT innervation. 
The celiac complex was analyzed in 8 animals, and 6/8 animals (75%) showed 
no signs of PRV infection, even though one female and one male showed minimal to 
moderate PRV-labeled cell bodies in the celiac ganglion (data not shown). We 
concluded that the celiac-superior mesenteric complex does not contribute to iWAT 
innervation. In the rare cases with PRV labeling in the celiac-superior mesenteric 
complex the injections may have unintentional punctured an indiscriminate area 
innervated by the celiac-superior mesenteric complex or PRV may have diffused from 
subcutaneous depots through the (in rodents typically open) vaginal process of the 
inguinal canal125. 
Next, we looked for evidence of PRV labeling in DRG sensory neurons. In a 
similar study of interscapular brown adipose tissue derived PRV labeling, we identified a 
low, but consistent PRV labeling in the DRG122. In contrast to interscapular brown 
adipose tissue (iBAT)-related labeling, DRG ganglia showed only occasional PRV 
labeling with typically <5 neurons per ganglion and most often observed in DRG T11 
(46% of analyzed animals) and T12 (30% of analyzed animals, Appendix C). We noted 
that iWAT derived PRV was not co-localized with TH-positive DRG neurons which lack 
authentic catecholaminergic functions126. Our finding is consistent with another report 
indicating that TH-positive DRG neurons, which often contained also calcitonin-gene 
related peptide (CGRP), may rather innervate the colorectum and urinary bladder 




Figure 3.2. Sympathetic postganglionic innervation of iWAT. A. Mice were injected with 
the retrograde, transsynaptic tracer PRVGFP into the right iWAT pad. Perfusion and 
tissue harvest was performed 3-4 days post-viral injection. Whole body iDISCO for TH 
peptide (B and C) and PRV (B’ and C’) imaged under a confocal microscope (10x 
objective) of a 12 weeks old female mouse. In the merged image (B” and C”) 
retrogradely labeled postganglionic sympathetic neurons can be seen in the right chain 
ganglia, T13 and L1. D. Summary of ganglionic labeling (positive cases/total number of 
mice) showing most consistent labeling in T12 to L1. 
 
We further ensured that “off-target” labeling was not due to an overall viral 
leakage, and dripped the same volume and titer of PRV onto iWAT tissue. In all five  
negative control animals, virus drip-on was insufficient to infect sympathetic chain 
ganglia, celiac-superior mesenteric complex, and DRG with PRV (Appendix C).  
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3.3.4. Preganglionic sympathetic neurons innervating iWAT are located in the IML 
of the spinal cord spanning from T7 to T10 
 
In order to allow imaging of preganglionic neurons in the spinal cord, all animals 
received a laminectomy prior to staining procedures. We imaged specimens from their 
dorsal side with either light sheet or confocal microscopy (Fig. 3.3.A). PRV labeling was 
predominant in the ipsilateral IML, but we also noted consistent PRV labeling in the 
intercalated (ICl) and central autonomic (CA) nuclei and some contralateral cells (Fig. 
3.3.A). It should be noted that PRV tracing from peripheral organs to the spinal cord 
also labels interneurons in addition to sympathetic preganglionic neurons, due to further 
propagation of the transsynaptic PRV infection128-130. In line with that, and because 
tracer labeling was absent in contralateral SChG, we interpreted PRV labeled 
contralateral neurons as interneurons.  
The spinal root entry defines the middle of the according spinal segment. In three 
mice, we verified that thoracic SChG from T1 to T12 correlate well with the level of the 
DRG (Fig. 3.3.B) and the according dorsal root entry into the spinal cord, which is 
shifted slightly rostral (Fig. 3.3.C). Thus, for data analysis of PRV labeling in iWAT 
related preganglionic neurons we used sympathetic chain ganglia as a proxy to 
determine their segmental level. Preganglionic labeling was restricted to the thoracic 
spinal cord, with consistent labeling at T7-T10 in the majority of analyzed animals (82-
91%), even though some cases included more rostral (T5) or caudal (T11) labeling 
(36%) (Fig. 3.4.A, Appendix C). Thus, iWAT-related preganglionic neurons (T7-T10) 
show a significant segmental rostral shift with respect to postganglionic PRV labeled 
neurons (T13-L1) as highlighted schematically in Fig. 3.4.B. 
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Figure 3.3. Preganglionic sympathetic neurons related to iWAT in the spinal cord in 
iDISCO preparation. A: Most preganglionic neurons labeled transsynaptically with PRV 
from iWAT are located in the IML (white arrows), while a significant number is detected 
in the intercalated (filled arrow heads) and central autonomic nuclei (open arrowheads); 
confocal microscope, 10x objective. B: In a 3D stack with overlaying TH 
immunofluorescence, the levels of sympathetic chain ganglia (red) serve as proxies for 
spinal cord segments. The location of DRG and according SChG is indicated, but only 
faintly visible. Light sheet microscopy, 0.63x zoom factor. B’: In a slice image the 
individual dorsal root ganglia and according dorsal roots (white arrows) are visualized 
as they enter the SC, which defines the middle of the according spinal cord segment. 
Light sheet microscopy, 0.63x zoom factor. Note, that lower sympathetic chain ganglia 
may serve as a proxy for spinal segments due to the increasing elongation of spinal 





3.3.5. Dissection and iDISCO clearing reveal two major access routes of 
sympathetic nerves to iWAT 
 
Next, we aimed to define the peripheral neural pathway, which can guide sympathetic 
postganglionic axons to the iWAT endorgan. Initially, we used bright field guided 
dissection and imaging to identify the sympathetic nerve inputs to dorsolumbar iWAT. 
We located the exit points of lateral cutaneous rami from intercostal nerves T11 to T13 
through the fascia and traced them to iWAT and skin (Fig. 3.5.A) as highlighted 
schematically in Fig. 3.5.B. The dorsolateral portion of iWAT is further innervated by the 
ilioinguinal (ILI) and the lateral cutaneous femoral nerves (LCFN, Fig. 3.6.A,B), which 
are both derived from the lumbar plexus. 
The inguinal portion of the iWAT is entirely innervated by nerves that are derived 
from the lumbar plexus, which provides overall innervation to the ventral thigh.           
Fig. 3.6.C shows the inguinal portion of the iWAT in more detail. The major nerves 
visible in this view are the femoral nerve mainly derived from ventral rami of spinal 
nerves (L1-3), from which the anterior cutaneous femoral nerve (ACFN) branches off 
and enters the inguinal division of the iWAT depot (Figure 3.6.C). Further details of the 
innervation are visible upon removal of the overlying WAT, showing further branching of 
the LCFN and anastomoses with a branch of the ACFN (Fig. 3.6.D). 
The complexity of the intercostal nerves and lumbar plexus nerves carrying 
sympathetic postganglionic fibers is not fully represented by stereomicroscopic images. 
Thus, we further dissected the entire iWAT depot and performed iDISCO staining for TH 
peptide and CD31 for better visualization of incoming major nerve fibers and 
vasculature (Fig. 3.7.A, A’).  
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Figure 3.4. Pre-and postganglionic innervation of iWAT. A: Diagrammatic representation 
of spinal cord segments (SCS) with PRV-positive preganglionic neurons (n positive / n 
total number of mice) in IML, IC and CA. Preganglionic iWAT innervation is observed 
from T5 to T12, but is most consistent across animals from T7 to T10. B: Diagrammatic 
synopsis of pre- (green) and postganglionic (red) iWAT innervation. Note, the diagram 
only includes consistent pre- and postganglionic labeling sites. Also note the significant 
segmental caudal shift of postganglionic PRV labeling with respect to preganglionic 
innervation. 
 
For orientation, we adopted the anatomical labeling and distinction of two iWAT portions 
that are roughly separated by a prominent lymph node in the WAT depot131: the 
dorsolumbar and inguinal depot. We consistently observed one major, prominent nerve 
entering the inguinal portion of iWAT that is consistent with the anterior cutaneous 
femoral nerve (Fig. 3.6.C). In the dorsolumbar portion, we identified several incoming 
nerves (Fig. 3.7.A depicts 3 incoming nerves with asterisk).  
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Figure 3.5. Sympathetic chain ganglia T11-T13 provide sympathetic innervation to 
dorsolumbar WAT via lateral cutaneous nerves. A: Distribution of lateral cutaneous rami 
of intercostal nerves T11 to T13 to dorsolateral iWAT (dl) as seen under the 
stereomicroscope (0.5x objective). Yellow dots indicate exit of dorsal cutaneous rami 
T11 to T13 through the external oblique abdominal muscle (exobl) and fascia as 
landmarks for spinal nerve identification. B: Scheme of lower thoracic spinal nerve 
branching emphasizing lateral cutaneous branches to iWAT. 
 
We found no consistency in the anatomical orientation of these nerves within dissected 
iWAT tissue, but they are consistent with the lateral cutaneous rami T11-T13 
documented earlier (Fig. 3.5.A).  
Furthermore, we assembled a schematic of the intercostal and lumbar plexus 
nerves as observed by stereomicroscope dissection in the mouse (Fig. 3.7.B). We 
found that all lateral cutaneous rami of intercostal nerves T11-13 and cutaneous rami of 
the lumbar plexus provide innervation to the adipose tissue, skin, and vasculature. 
Thus, these innervation systems seem highly intertwined and should receive 
consideration specifically in denervation studies where innervation of vasculature, skin 
and adipocytes will be likely similarly affected.  
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3.3.6. Varicose innervation density is sparse among white adipocytes, but dense 
among brown adipocytes within iWAT 
 
Apart from the prominent main innervation branches depicted in Fig. 3.7.A, a grainier 
TH-positive structure is visible. This structure seemed to represent areas with increased 
density of axonal varicosities, even though the resolution of light sheet or confocal 
images in cleared tissue samples was insufficient to fully resolve this. In a paraffin, 
longitudinal section through the iWAT the location of beige islands, that show increased 
accumulation of brown adipocytes (also known as beige or brite adipocytes), is visible 
(Fig. 3.8.A, purple arrows). Immunohistochemical staining of adjacent sections for TH-
peptide and uncoupling protein 1 (UCP1) demonstrates the stark difference in axonal 
varicosity density of UCP1 void areas (Fig. 3.8.B, B’) versus UCP1-rich areas (Fig. 
3.8.C,C’). Further details of an iDISCO cleared iWAT sample further depicts an area 
that shows neuronal branching with axonal varicosities into a beige island in close 
proximity to the lymph node (Fig. 3.8.D). For clarity, the image was reproduced as a 
schematic in (Fig. 3.8.E). 
3.4. Discussion 
Our study aimed to allow a comprehensive, rigorous and transparent evaluation of pre-
and postganglionic sympathetic inputs to iWAT in male and female mice. Our goal was 
also that our work would be useful for future studies that use virus-driven 
neuromodulation in select adipose tissue depots.  
Our PRV based study demonstrates sympathetic chain ganglia T12-L1 as major 
postganglionic input to iWAT, and is similar to data in other rodent models100,119. 
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Figure 3.6. Peripheral nerves to right iWAT in a 3 week old female TH:tomato mouse in 
brightfield (A) and fluorescence (B-D) stereomicroscope, ventral view. A. Brightfield 
overview (0.5x objective) of the right dorsolateral (dl) and inguinal (ing) portions of 
iWAT. The thoracoepigastric vein (thev) is visible at the cranial tip of the dl and the 
superficial ilium circumflex vein (sicv) is visible at the dl/ing iWAT junction. The femoral 
nerve (FN) appears upon its passage under the inguinal ligament (dotted) through the 
muscular lacuna. Medially, the femoral artery and vein (avf) are passing through the 
vascular lacuna. B. The upper rectangle in A imaged at higher magnification under the 
fluorescent microscope (0.5x objective). Intercostal (subcostal) T13, iliohypogastric 
(IHG), the fine ilioinguinal (ILI, open arrowheads) and lateral cutaneous femoral (LCFN) 
nerves and the iliolumbar artery and vein (avil) travel to the dorsolateral portion. Dashed 
contour indicates lymph node (ly) at dl/ing junction; exobl denotes external oblique 





C. Lower rectangle of A imaged at higher magnification under the fluorescent 
microscope (0.5x objective). The LCFN is seen approaching the dl/ing junction of iWAT. 
The main branches of the femoral nerve (FNm – motor branch to thigh extensor 
muscles, SAPH – saphenous nerve, ACFN – anterior cutaneous femoral nerve) are 
visible. The ACFN enters the inguinal portion and eventually exits to skin (cut, asterisk). 
D. The rectangle in C imaged at higher magnification. Upon removing the overlying 
WAT, the LCFN divides. One branch (double asterisk) anastomoses with a fine branch 
of ACFN (open arrowhead) deep within the inguinal portion. Bright fluorescent artifacts 
at dl/ing junction typically occur after longer exposure on WAT surface.  
 
Recent reports have suggested that iWAT in mice may be purely innervated by the 
celiac complex107,132, even though the celiac ganglia are thought to provide sympathetic 
innervation for abdominal structures like liver, kidney and gastrointestinal organs133. In 
our study, we rarely found labeling within celiac ganglia or the celiac-superior 
mesenteric complex. We note that tracer injections to the iWAT are particularly prone to 
tracer diffusion from subcutaneous depots through the vaginal process (in rodents 
typically open) of the inguinal canal into the peritoneal cavity125. Specifically, large 
injection volumes and long incubation times may enhance the risk of diffusion through 
the inguinal canal, eventually labeling neurons that innervate intraperitoneal organs. 
Indeed, Jiang et al used a total tracer volume of 5 µL choleratoxin B with a 7-day 
incubation time compared a total PRV injection volume of 1-2 µL and 4 days incubation 
time in the present study. This further highlights the importance of our study to define 
reproducible labeling patterns for endorgan innervation, so that future approaches for 
viral targeting of the peripheral nervous system continues the same rigor as established 
for virus spread in the CNS134-137. 
The findings presented here confirm postganglionic innervation from T13 and L1, 
which was found by others in rats and hamsters100,119.  
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Figure 3.7. iDISCO tissue clearing shows main innervation branches to iWAT. A. Light 
sheet images of an iWAT depot, stained and cleared with iDISCO for TH-peptide (red = 
sympathetic innervation) and CD31 (green= vasculature and lymph node (ly)). The 
dorsolateral innervation shows several incoming branches (asterisk) that cannot be 
conclusively assigned to individual nerves, but should represent lateral cutaneous rami 
from T11-T13. In the inguinal portion one prominent incoming branch can be 
consistently identified that we conclude is the ACFN, which is also the most prominent 
nerve visible under the stereomicroscope. B. Schematic drawing of the lumbar 
sympathetic plexus that provides innervation to the thigh, including adipose tissue, 
vasculature and skin.  
 
Another study in the hamster also found sympathetic inputs to iWAT from T12-L3, and 
additionally input from T1-T3 chain ganglia, with extensive overlap of sympathetic input 
to iBAT and iWAT63. In contrast, the present study showed a more restricted input to 
iWAT (SChG T12-L1). None of our animals showed PRV labeling in rostral thoracic 
SChG (stellate/T1-T5), which we recently demonstrated as the main sympathetic input 
to iBAT122. Importantly, our data suggests an anatomical separation of postganglionic 
input to iBAT vs iWAT. We speculate that the discrepancies of our study with Nguen et 
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al 63 are likely due to the extended PRV incubation time (6 days vs. 4 days in our study), 
as their aim was also to study overlapping patterns in CNS structures that require longer 
incubation time. Thus, while the ability of PRV for transsynaptic labeling is an advantage 
to identify circuits, it is important to recognize the possibility for transsynaptic labeling 
within pre-and postganglionic neurons with increasing incubation time, and has been 
demonstrated for spinal cord interneurons128-130.  
We further show that the preganglionic input to iWAT (T7-T10) was also 
anatomically distinct from preganglionic input to iBAT (T2-T6)122. We were unable to find 
other published work that anatomically defined the rostro-caudal extent of preganglionic 
input to iWAT or iBAT in the spinal cord. Importantly, our data suggest that both pre-and 
postganglionic inputs to iBAT and iWAT are anatomically separated.  
Our data provide the anatomical basis to suggest that CNS inputs could 
differentially regulate the sympathetic tone to iBAT vs. iWAT. This is in line with a recent 
study indicating that hypothalamic proopiomelanocortin (Pomc) expressing neurons and 
agouti related peptide (Agrp) expressing neurons both regulate the sympathetic tone to 
iBAT, while sympathetic tone to iWAT was only regulated by Pomc neurons, but not 
Agrp neurons138. This is also relevant, as several studies have now suggested that 
sympathetic activation of BAT might not be sufficient to induce BAT thermogenesis and 
might require additional sympathetic activation of WAT139-141. Future studies will need to 
address if known preganglionic inputs from the CNS may selectively regulate iBAT and 
iWAT sympathetic circuits.  
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The clear anatomical separation of both pre- and postganglionic neurons innervating 
iWAT and iBAT, respectively, may facilitate future experimental studies on differential 
forebrain control of brown and white adipose tissues. 
Sympathetic postganglionic axons travel via dorsal and ventral rami to their end 
organs, which combine sensory fibers from dorsal root ganglia and, via communicating 
rami, postganglionic fibers from SChG. Our anatomical dissections show that major 
incoming nerves to the dorsolumbar portion of iWAT are lateral cutaneous branches of 
intercostal nerves. Indeed, iWAT-related PRV labeling of SChG is consistent with the 
innervation from intercostal nerves T12 to L1, which represent ventral rami of spinal 
nerves in that area.  
Likewise, we found that the inguinal portion of iWAT is innervated via nerves 
derived from the lumbar plexus, which is also formed by ventral rami of spinal nerves, 
with a branch of the femoral nerve (L1-3) and the lateral cutaneous nerve of the thigh 
(L2). iWAT-related postganglionic neurons in chain ganglia L1-L3 send their axon 
through the communicating rami into these nerves. However, also lower thoracic chain 
ganglia, e.g. T12 and T13 may connect to the lumbar plexus nerve, as a particular 
spinal nerve receives postganglionic axons from both, the next cranial and also the next 
caudal chain ganglia14. As no PRV labeled postganglionic neurons were found in 
sympathetic ganglia caudal to L2, we speculate that this reflects PRV concentration into 
the dorsolumbar iWAT, which is consistent with our dorsal injection approach that might 
have unintentionally favored viral uptake into nerves to the dorsolumbar iWAT. Also, we 
cannot rule out that fat mass expansion with aging or obesity could further recruit 
innervation from more rostral or caudal sympathetic chain ganglia.  
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Interestingly, it has been noted by others that the dorsolumbar and inguinal 
portions show functional distinctions142: The inguinal portion is more prone to beiging 
and shows denser sympathetic innervation than the dorsolumbar portion. Thus, it is 
interesting to speculate if and how the anterior femoral nerve contributes to the 
increased beiging. Our data are the first to provide detailed maps for sympathetic 
nerves of iWAT. We further translate these data to 3D iDISCO imaging data in iWAT, so 
that a more targeted investigation and distinction of dorsolumbar vs. inguinal innervation 
patterns is encouraged for future studies.  
Importantly, varicose innervation density is strongly associated with adipose 
tissue structure. In iWAT, dense varicosities are mainly associated with arteries, while 
white adipocytes show sparse varicose innervation. In contrast, brown adipocytes 
clustered in beige islands, strongly correlate with increased varicose innervation pattern. 
Thus, dynamic interaction of neurotrophic repulsion and attraction, similar to autonomic 
innervation guidance during development 105,143, are likely responsible for the robust 
difference in innervation patterns of white and brown adipocytes, respectively. However, 
the dynamic changes of varicose endings at the interface of white and brown adipocytes 
remains unstudied. Some studies used the dense network of sympathetic nerves to 
measure iWAT innervation density107,131, but this may not well represent the varicose 
innervation pattern at the interface of white and brown adipocytes, as it is the number of 
individual varicosities that dictate the amount of neurotransmitter release and thus, 
degree of sympathetic action144. 
Our data also clarify that nerves supplying the iWAT are continuous structures 
that transition through the adipose tissue further to the skin.  
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Figure 3.8. Varicose innervation density depends on white versus brown adipocyte 
innervation. A. Hematoxilin and Eosin staining  (stains cytoplasmatic content purple) of 
a paraffin-embedded longitudinal section (5 μm) of iWAT shows the prominent lymph 
node (ly) at the junction of dorsolumbar (dl) and inguinal (ing) portions of iWAT 
(confocal microscopy, 5x objective). Areas with mainly white adipocytes appear light 
purple (rectangle to B), due to the reduced cytoplasmatic content of white adipocytes. 
Areas with darker purple stain depict areas with increased number of brown adipocytes 
(beige islands, purple arrows and rectangle to C), which contain more coplasm than 
white adipocytes.  
(fig. cont’d) 
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The upper square depicts an area with mostly white adipocytes. Staining of an adjacent 
section with TH-peptide (B) and the brown adipocyte marker, UCP1 (B’) shows that low 
TH-positive varicosities are found among UCP1-negative white adipocytes. The lower 
square depicts an area with mostly brown adipocytes. Staining of an adjacent section 
with TH-peptide (C) and UCP1 (C’) shows that high TH-positive varicosities are found 
among UCP1-positive brown adipocytes. D. Confocal image (5x objective) of iWAT 
iDISCO cleared and stained for TH-peptide and the vascular marker CD31. Apart from 
the major TH-positive nerves, a more grainy TH labeling of axonal varicosities is seen. 
Co-localization with CD31 shows dense varicosites associated with arterial vasculature. 
Beige islands with brown adipocytes can be identified by dense varicosities, while areas 
with mostly white adipocytes show low varicosity density. E. The schematic drawing of 
the confocal image in D clarifies the observed pattern of axonal varicosites associated 
with arteries, brown and white adipocytes. 
 
Fine nerves branch off from these rami to reach deeper into the adipose tissue and 
provide a dense plexus of varicose axons especially to the smooth muscle media of 
small arteries and arterioles. Varicosities are sparse adjacent to white adipocytes, even 
though beige islands with brown adipocytes show a visibly denser varicosity pattern. It 
should be noted that surgical iWAT denervation, likely by cutting the lateral cutaneous 
rami and lumbar plexus incoming nerves145, will remove innervation to iWAT, but also to 
the skin and vasculature. To selectively cut iWAT-specific branches off the rami is likely 
not feasible, and therefore the confounding effects of skin and vasculature denervation 
should be considered in future surgical denervation studies. Alternatively, chemical 
denervation has been successfully used with comparable results to surgical 
denervation146, where the chemical toxin is directly injected into the adipose tissue 
depot. We predict that this method is more suitable to selectively denervate adipose 
tissue, while sparing innervation to further downstream structures like the skin that are 
jointly innervated by the same rami. We also suggest that future denervation studies 
(surgical or chemical) to include histological verification of the denervation extent with a 
focus on structures that share innervation via the same rami. 
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Furthermore, the precise anatomical identification of pre-and postganglionic 
innervation in the mouse should be a guide to verify correct viral labeling e.g. using 
virus-driven expression of chemo-or optogenetic constructs, that are based on 
retrograde tracing methods. Furthermore, animals should be inspected for off-target 
labeling in the celiac ganglion, as they are inconsistent with iWAT innervation.  Also, we 
currently have little understanding if all iWAT innervating nerves serve the same 
purpose, and past electric recordings of adipose tissue innervation lacked anatomical 
definition which nerves were recorded and if they included skin and vascular innervation 
or if more specific iWAT related recording is feasible138. Our work enables future studies 
to provide anatomical detail about the nerves targeted. Another consideration is also the 
density of axonal varicosities as they are variable within the iWAT depot with dense 
varicosities in areas with high brown adipocytes (beige islands) and sparse varicosities 
adjacent to white adipocytes. We speculate that the density of varicosities could affect 
viral uptake and retrograde tracing efficiency. Indeed, in an earlier study we found that 
PRV incubation times after injection into the iBAT required less incubation time122 than 
after injection into iWAT. Such dynamics will require more rigorous examination in the 
peripheral nervous system when comparing mouse models with increased or decreased 
innervation (e.g. due to obesity or chronic cold exposure).  
In summary, our data provide a comprehensive study to precisely define pre- and 
postganglionic sympathetic inputs to inguinal and dorsolumbar adipose iWAT tissue in 
male and female mice that are distinct from pre-and postganglionic inputs to BAT.  
 
 59 
These studies should serve as a guide for a rigorous and transparent method to verify 
proper viral infections for molecular genetic tracing of adipose tissue specific 






















Chapter 4. Summary, Outlook, and Significance 
4.1. Research summary 
4.1.1 Independent sympathetic inputs of iBAT and iWAT 
 
In Chapters 2 and 3, we detailed the sympathetic innervation of iBAT and iWAT through 
the use of reporter mice, viral retrograde tracing, large-volume tissue clearance, and 
light sheet microscope. To our knowledge, an anatomical diagram that depicts the 
spatial orientation of SChG, the spinal cord and column, and the spinal nerves had not 
been generated for the mouse. In Fig. 4.1, a schematic accurately displays the 
distribution of these structures.  
In addition, Fig. 4.1 comprises the viral tracing results from both iBAT and iWAT 
datasets. Visualizing the data in this manner emphasizes the separation of the pre- and 
postganglionic inputs between the two fat pads, as they arise from distinct anatomical 
levels. This is a significant shift from earlier views, which indicated that iBAT and iWAT 
may have joint innervation circuits63. Our findings can be further substantiated upon 
examination of the physical location of each fat pad.   
We report that the sympathetic postganglionic neurons that innervate iBAT are 
located at approximately the same vertebral level of their according preganglionic inputs 
(Figure 4.1). This is because the iBAT receives input from the SChG that emanate at 
the level of the upper thoracic vertebrae. Due to the articulations between the upper 
thoracic vertebrae and the ribs, these vertebrae are rigid in relation to other regions the 
of vertebral column, which have a greater degree of curvature147. 
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Figure 4.1. The distinct pre- and postganglionic sympathetic inputs of iBAT and iWAT 
using PRV retrograde tracing. Unilateral PRV injection into the iBAT resulted in labeling 
of SChG SG-T5. As the SG is often described as being “fused” to SChG T1, labeling of 
preganglionic inputs in the spinal cord are found at the anatomical level T1-T5. When 
PRV is unilaterally injected into the iWAT, labeling is found in SChG T12-L1. During 
childhood development, the spinal cord no longer elongates as the vertebral column 
does. The spinal nerves move farther away from their original position relative to the 




During development, the degree of curvature in the spine decreases, which elongates 
the vertebral column148. However, the spinal cord does not elongate equally, making the 
spinal cord shorter than the vertebral column149. Therefore, pre- and postganglionic 
inputs of the iBAT appear at approximately the same vertebral level. In contrast, the 
postganglionic neurons that innervate iWAT are located caudal to their preganglionic 
neurons (Figure 4.1). This finding is in agreement with the understanding that 
postganglionic inputs innervate peripheral structures located at the same spinal 
segment150, as seen with the SChG that innervate iWAT. 
Furthermore, the spinal cord is organized into 31 segments that are defined by 
31 pairs of nerves (cervical (8), thoracic (12), lumbar (5), sacral (5), and coccygeal (1)). 
Each spinal segment contains organs, skin, and muscles in which the according spinal 
nerve innervates148. Overlap between neighboring segments exists151, as the human 
sciatic nerve is formed by the combination of five spinal nerves (L4, L5, S1, S2, S3)152, 
indicating five different spinal segments. However, the most caudal spinal nerve 
innervating iBAT is T5, and the most rostral spinal nerve innervating iWAT is T12. The 
distance between spinal segments T5 and T12 further supports our conclusion that 
iBAT and iWAT are innervated by differential sympathetic nerves that are unlikely to 
overlap.  
One can speculate that previous work demonstrating an overlap in iBAT and 
iWAT sympathetic input could have arisen from virus incubation time. At most, we 
allowed for a 4d incubation period post-injection. Conversely, Nguyen et al. (2017) 
performed iBAT and iWAT injections in the same hamster and allowed for a 6d 
incubation time63. Given that PRV is a retrograde transsynaptic tracer, the two additional 
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days could allow PRV that was injected into iWAT to also label the SChG innervating 
iBAT, causing a perceived overlap in sympathetic inputs.  
Altogether, these findings give way to the possibility that a differential central 
control of the fat pads exist. In an experiment by Bell et al. (2017), deletion of leptin 
receptors (LEPR) on POMC and AgRP neurons partially blunted the typical, leptin-
evoked increase in sympathetic nerve activity observed in BAT. However, loss of LEPR 
in AgRP neurons, but not POMC neurons, interfered with leptin-induced sympathetic 
nerve activity to iWAT and the liver138. This data suggests that leptin engages different 
neuronal populations to control the sympathetic nerve activity of distinct tissues.  
There is also data that a differential SNS activation of adipose tissues exist via 
melanocortin receptor stimulation153. Melanocortins, which are peptide hormones 
adrenocorticotropic hormone (ACTH) and melanocyte-stimulating hormone (MSH) 
cleaved from POMC, control energy intake and expenditure. Upon central injection of 
melanotan II, a melanocortin 3/4-receptor agonist known to decrease adiposity, 
differential sympathetic drives to iBAT and iWAT were observed. Using norepinephrine 
turnover as a measurement of sympathetic drive, it was found that MTII increased 
sympathetic drive in iWAT, but not iBAT. Furthermore, central MTII did not increase 
sympathetic drive of epididymal WAT or retroperitoneal WAT. Taken together, these 
results not only demonstrate a difference between iWAT and iBAT, but also between 
WAT depots. To further substantiate these findings, a future study could use a 
melanocortin 4 receptor reporter (MC4R) mouse and our anatomical labeling maps of 
the IML to determine if their location corresponds to the location of the preganglionic cell 
bodies of iBAT and iWAT. If a significant discrepancy in the distribution of melanocortin 
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4 receptors is evident, this could be the first indication for why there was a difference in 
the sympathetic drives. This hypothesis could be tested by injecting PRV into the 
different fat pads of MC4R mice and analyzing the amount of co-localization between 
PRV and MC4R in the IML. Collectively, our viral tracing and anatomical data in 
conjunction to the findings described in the literature, strongly supports the notion that 
iBAT and iWAT possess distinct sympathetic inputs.  
4.1.2. PRV-labeled preganglionic cells may provide new understanding of adipose 
depot connection to CNS  
  
The combination of whole-body tissue clearance and high-resolution imaging resulted in 
the ability to image the entire thoracic and lumbar region of the spinal cord, distinguish 
spinal cord nuclei, and identify the vertebral level at which the PRV-labeled cells were 
located. As depicted in Fig. 4.2.A, the grey matter of the spinal cord is distinguished by 
nuclei and Rexed laminae. Spinal cord nuclei are determined by cell location, whereas 
Rexed laminae are ten layers that are grouped according to the cell’s structure and 
function. Also, PRVGFP labeling was restricted to the right side of the spinal cord (Fig. 
4.2.B), ipsilateral to the fat pad that received the injection, indicating that our tracer was 
specific and viral leakage did not occur. 
Our studies revealed that the positively labeled, preganglionic cells of the spinal 
cord were located in the IML, ICl, and CA; which can also be characterized as Lamina 
VII (IML, ICl) and X (CA). The IML, ICl and CA are the sites in which sympathetic 
preganglionic neurons are located154, which provides as additional confirmation 
because these are the specific regions in the spinal cord that we observed PRVGFP 
labeling (Fig. 4.2). Furthermore, it has been reported that the dendrites from the IML, 
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ICl, and CA form dendritic bundles that traverse the spinal cord154-156, a detail that we 
could clearly observe in Fig. 4.2. Our findings in the spinal cord are meaningful in that 
they can provide additional understanding to the sympathetic circuitry innervating iBAT 
and iWAT.   
In 2014, Madden and Morrison elegantly outlined a proposed thermoregulatory 
network of BAT157. Ambient temperature is sensed by cold and warm cutaneous thermal 
sensory receptors that send information via afferent pathways to the preoptic area 
(POA). The POA functions to modulate the central thermoregulatory response by 
controlling sympathetic output to many organs, most notably BAT158, and it has also 
been speculated that the POA is similarly involved in the browning of beige adipocytes 
found in WAT depots159.  In the instance of cold exposure, a stimulus for BAT activation, 
POA warm-sensing neurons inhibit BAT sympathoexcitatory neurons in the dorsomedial 
hypothalamus (DMH)157,158. The disinhibition of the neurons in the DMH excite BAT 
sympathetic premotor neurons in the rostral raphe pallidus (rRPA) and parapyramidal 
area (PAPy). Serotonergic (5-hydroxytryptamine, 5-HT) premotor neurons descend from 
the rRPA and PAPy and terminate in close proximity to GABAergic interneurons in the 
CA of the spinal cord160. Serotonin plays a vital role in the excitation of the BAT 
sympathetic preganglionic neurons in the spinal cord, as it has been demonstrated to 
potentiate the excitatory inputs to BAT sympathetic preganglionic neurons from the 
rRPA. It has been postulated that the serotonergic inputs descending from the rRPA 




Figure 4.2. Peripheral PRVGFP injections into iWAT fat pad labels the intermediolateral 
(IML), intercalated (ICl), and central autonomic (CA) nuclei of the spinal cord. A) In 
lamina VII, the preganglionic cell columns of the autonomic nervous system are located 
in the IML, ICl, and CA. The preganglionic sympathetic neurons in the IML extend their 
dendrites in a transverse manner, where they reach the ICl. The ICl acts to connect the 
IML to the CA. Unilateral injection of PRV into the fat pad resulted in PRV-labeled cell 
bodies in the IML, ICl, and CA (labeled in green, B). These findings indicate that PRV 
labeling in the spinal cord nuclei is ipsilateral to the injected fat pad and that PRV 
labeling is restricted to nuclei that contain sympathetic cell bodies. 
 
Inhibition of GABAergic interneurons allows for increased sympathetic outflow, as the 
inhibitory effect of the GABAergic interneurons to BAT sympathetic preganglionic 
neurons is now absent157,161,162. Since our methods enable one to simultaneously 
immunolabel and visualize the physical connections between spinal cord nuclei (Fig. 
4.2.B), this poses as an intriguing opportunity to shed new light on the hypothesized 
circuit. 
A future study could involve PRV injection into the iBAT of vesicular GABAergic 
transporter (VGAT) reporter mice. 
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Use of VGAT reporter mice will function as a marker of the precise location of the 
GABAergic cell population in the spinal cord, as it appears that the CA and IML are 
used interchangeably across different publications. Furthermore, previous studies lack 
photograph evidence documenting the spinal cord and its nuclei157,160-162. Next, iDISCO 
processing would include an immunolabel for PRVGFP, 5-HT, and the VGAT reporter 
mice. 
First, we would seek to verify that PRV labeling was evident in SChG SG-T5. We 
would then determine if PRVGFP cells (marker for BAT sympathetic preganglionic 
neurons) have a close association with VGAT-labeled fibers in the IML, which would 
provide evidence that GABAergic interneurons synapse onto BAT sympathetic 
preganglionic neurons. Next, verify if and where the cell bodies of the GABAergic 
interneurons of the spinal cord appear to make close contact with 5-HT labeled fibers. In 
the brain, we would analyze the cell bodies in the rRPA-PAPy for co-localization of 
PRVGFP and 5-HT. If successful, this study would provide compelling visual evidence of 
the proposed pathway.  
4.2. Outlook 
4.2.1.  Current status of adipose-specific SNS stimulation  
Ideally, our goal is to utilize the results described in Chapters 2 and 3 to generate a 
tissue-specific SNS stimulation technique with the hypothesis that an iBAT- or iWAT-
specific SNS stimulation via ß3-adrenoreceptors will stimulate thermogenesis or 
lipolysis in diet-induced obese mice. In turn, this would exclusively enhance adipose 
tissue function while avoiding the dangerous potential side effects of systemic ß3-
adrenoreceptor agonist compounds163. ß3-adrenoreceptor agonist drugs have fallen out 
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of favor because ß3-adrenoreceptors have been indicated to participate in the 
pathogenesis of cardiac failure164-166, so any compound that would exacerbate the 
development of cardiovascular disease is not ideal. 
A major criticism in developing an intervention that exclusively stimulates the 
SNS in fat pads points to the evidence that the SNS is pathologically overactive in 
obesity167. This suggests that increased stimulation via the SNS is not only ineffective 
for weight loss, but dangerous to human health. Metabolic syndrome (MetS) is a health 
condition characterized by the co-occurrence of obesity, hypertension, dyslipidemia, 
insulin resistance, and hyperglycemia. Interestingly, data from MetS patients is 
described as chronic sympathoexcitation, resulting in increased urinary noradrenaline 
levels, efferent muscle sympathetic nerve activity, and rates of plasma noradrenaline 
spillover. In fact, a handful of symptoms do provide evidence that could indicate 
sympathetic overactivity: insulin resistance, increase in HPA axis activity, leptin 
resistance168. However, this does not address the status of sympathetic activity in 
adipose tissue.  
The sympathetic tone in adipose tissue has been shown to be decreased in 
obese humans and rodents and have down-regulated ß-adrenoreceptors in WAT168. It is 
also believed that obese adipose tissues lose thermogenic capacity because of the 
expanding size of the depot, leading to impairment of the innervation and 
vascularization169,170, and ultimately sympathetic dysfunction171.  
As the functionality of sympathetic activity continues to be debated, it is more likely that 
both lines of thought exist contemporaneously, with some organs gaining an increase in 
sympathetic tone while others decrease168.  
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Despite arguments to the contrary, SNS stimulation has been a long-standing 
rationale for obesity therapeutics. The challenge lies in identifying the correct 
combination of tools and molecules to target in order to achieve the desired effects in 
vivo, while also keeping human application in mind. Previously, Zeng et. al. utilized 
optogenetics and TH-cre mice to locally stimulate the sympathetic nerve endings in 
iWAT, concluding that leptin drives sympathetic activation, wherein sympathetic nerve 
fibers make direct contact with adipocytes to release NE. While this methodology did 
indeed result in lipolysis and fat mass reduction, implantation of the optical fiber was 
invasive as it was implanted down the entire length of the back and therefore, poses 
concerns about feasibility for long-term use172. Also, this study was not conducted in 
diet-induced obese mice, so it remains to be seen if this method would prove successful 
in the mouse line that serves as a proxy for human obesity. 
Additionally, there is data that credits intracellular glycolysis being essential to 
NST in iBAT when induced via acute optogenetic stimulation. The role of glucose in 
NST presents an interesting line of thought because iBAT is a substantial depot for 
glucose uptake. Individuals with type 2 diabetes have impaired glucose metabolism in 
BAT, which indicates a possible cellular mechanism for the hyperglycemia exhibited in 
those with type 2 diabetes. However, body weight loss was not considered and 
represents a significant drawback, as the experiments were conducted under 
anesthesia and hence, acute in nature (3hr)173. Monitoring body weight is paramount 
because it is estimated that 85% of people with type 2 diabetes are overweight or 
obese174. To add, it has been routinely reported that the amount of BAT is inversely 
correlated with body mass in humans71,175. Therefore, future work should implement 
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BAT stimulation in awake, freely-moving wild-type and db/db mice (type 2 diabetes 
mouse model) to gain a more accurate understanding of the relationship between 
intracellular glycolysis in BAT, NST, and the possible impact in type 2 diabetes.  
Lastly, a recent publication provides proof-of-concept for wireless optogenetic 
implantation in iWAT. The wireless optogenetic device selectively stimulates calcium 
cycling in the iWAT of Adipo-ChR2 mice, initiating thermogenesis through the SERCA2b 
pump. This approach differs from our design as it targets adipocytes by exploiting the 
adiponectin gene expressed in every adipocyte versus targeting the SNS that 
innervates adipose tissue. Intriguingly, wireless optogenetics successfully increased 
whole-body EE in a thermoneutral environment and protected mice from obesity in the 
presence of HFD176. It must be noted that the success of this method is exclusive to the 
Adipo-Serca KO mouse line and not the wild-type littermate controls. Indeed, clinical 
trials using optogenetics-based therapies have been approved (clinicaltrials.gov 
NCT03326336)177, but it is not yet commonplace, and the addition of implanting a 
wireless device is another component to address. Taken together, a substantial 
undertaking lies in implementing this type of therapy in humans. 
In our ongoing efforts to chemogenetically stimulate sympathetic nerves of iBAT 
or iWAT, we utilize the innervation maps described herein to routinely verify that the 
viral constructs that are injected into distinct adipose depots properly target their 
according sympathetic chain ganglia. Furthermore, the visual verification and 
documentation of the virally-labeled sympathetic chain ganglia is an excellent method 
that works to ensure that our experiments are carried out with scientific rigor, 
transparency, and reproducibility. 
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4.3. Significance of research 
Extensive research has been conducted to identify the hypothalamic circuits involved in 
controlling the sympathetic nerve activity found in iBAT and iWAT. To that end, the 
sympathetic post-ganglionic inputs of iBAT and iWAT have also been 
documented100,101,119. In Chapters 2 and 3, we utilized these findings to verify our own 
labeling results and then, ultimately improve, the method to properly identifying SChG 
and other relevant structures through the use of reporter mice, PRV retrograde tracing, 
iDISCO tissue clearance, and lightsheet/confocal microscopy. Furthermore, our 
conclusion that iBAT and iWAT are served by separate sympathetic inputs is supported 
by the mounting evidence that separate neuronal populations govern the activity of each 
adipose depot138,153 
Additionally, our results can contribute to improving the precision capabilities of 
technology like pharmaco- and optogenetics because our detailed innervation map 
enables one to conclude where the virus was uptaken in the fat pad. For example, our 
dissection studies revealed that iWAT has the potential to receive innervation from 
SChG T12-L4; however, the most frequently labeled SChG were T12, L1. In the future, 
we can test if concentrating injections to the inguinal portion of the iWAT results in a 
higher incidence of SChG L2, L3, and L4 labeling. On the other hand, it is also possible 
that differences in innervation density (varicosities) that exist in a fat pad (fig. 3.8) could 
be responsible for this effect.  
In conclusion, we provide a complete map of SNS innervation to the iBAT and 
iWAT depot. These data document the identity and location of the pre- and 
postganglionic sympathetic neurons innervating iBAT and iWAT. We also hope that our 
 72 
findings can be utilized as a comprehensive anatomical resource for those interested in 
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Appendix B. Supplemental Data for Chapter 2 
Detailed information on mouse models, pseudorabies virus and antibody used 




























Antibody Chicken Anti-GFP Abcam Ab13970 AB_300798 Dilution 
1:400 
Antibody Rabbit anti-tyrosine 
hydroxylase 
Millipore AB152 AB_390204 Dilution 
1:500 
Antibody Donkey anti-rabbit IgG(H+L), 





A-31572 AB_162543 Dilution 
1:300 
Antibody Alexa fluor 647 – AffiniPure 


















Appendix B. Supplemental Data for Chapter 2 
Individual data for automated cell counts of PRV-GFP labeled neurons in sympathetic 













Gender	 Subject	 Stellate/T1	 T2	 T3	 T4	 T5	 T6	 T7	 total	
F	 BAT3	 1087	 173	 258	 293	 62	 5	 1	 1879	
F	 BAT7	 1310	 199	 199	 85	 165	 6	 0	 1964	
M	 BAT14	 196	 154	 150	 131	 121	 25	 4	 781	
M	 BAT25	 400	 222	 173	 158	 63	 0	 0	 1016	
F	 BAT26	 1059	 108	 165	 66	 110	 0	 0	 1508	
F	 BAT	87	 1507	 215	 281	 174	 4	 0	 0	 2181	
F	 BAT	88	 631	 402	 398	 296	 24	 20	 0	 1771	
F	 BAT	90	 509	 292	 211	 230	 208	 11	 0	 1461	
F	 BAT	92	 401	 285	 206	 220	 205	 10	 0	 1327	
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Appendix C. Supplemental Data for Chapter 3 
 
PRV labeling is occasionally found in dorsal root ganglia. Example of PRV labeling 
(green) in DRG at level T11 (A), T12 (B), T13 (C) and L1 (D). DRG neurons were easily 
identified by the existance of few, but consistent TH-positive neurons (red). PRV-
positive DRG neurons were consistently not co-localized with TH. Light sheet images, 










Appendix C. Supplemental Data for Chapter 3 
 
PRV injections into iWAT exclusively labels the sympathetic chain ganglia and IML. A-
C. Negative control “drip-on” tests were conducted in 5 mice. PRV administered onto 
the iWAT via this method provided no evidence of PRV labeling in the sympathetic 
chain ganglia (A, A’, light sheet microscope, 0.63x zoom factor), celiac ganglion (B, B’, 




















































Individual results for all animals of PRV-positive neurons found in sympathetic chain 
ganglia (A), dorsal root ganglia (B), Celiac ganglia (C), Intermediolateral bundle (D). 
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Appendix C. Supplemental Data for Chapter 3 
List of used resources.  











Antibody Anti-GFP Abcam ab13970 AB_300798 (1:400) 
Antibody Anti-Tyrosine Hydroxylase Millipore AB152 AB_390204 (1:500) 
Antibody CD31/PECAM-1 Novus Biologicals AF3628 AB_2161028 (1:300) 
Antibody 
Donkey anti-Goat IgG (H+L) 
Cross-Adsorbed Secondary 
Antibody, Alexa Fluor 488 
Thermo Fisher 
Scientific A-11055 AB_2534102 (1:300) 
Antibody 
Donkey anti-Rabbit IgG (H+L) 
Highly Cross-Adsorbed 
Secondary Antibody, Alexa 
Fluor 555 
Thermo Fisher 
Scientific A-31572 AB_162543 (1:300) 
Antibody 
Alexa Fluor 647-AffiniPure 
F(ab')2 Fragment Donkey Anti-








155 AB_2340380 (1:300) 
Data processing 








breeding pairs were 
obtained from Dr. 
































PRV-Bartha containing the 
CMV-EGFP reporter gene 
cassette inserted into the gG 




PRV-152   
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